Page last updated: 2024-10-28

glyburide and Pregnancy

glyburide has been researched along with Pregnancy in 252 studies

Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.

Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.

Research Excerpts

ExcerptRelevanceReference
" The relationships between glyburide concentration and the time since the last intake of glyburide and between fetal glyburide concentration and neonatal hypoglycemia were modeled with linear or logistic regressions using fractional polynomials."9.34Transplacental transfer of glyburide in women with gestational diabetes and neonatal hypoglycemia risk. ( Alvarez, JC; Bouchghoul, H; Bouyer, J; Senat, MV; Verstuyft, C, 2020)
"Metformin has been reported to reduce the risk of pre-eclampsia."8.98Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta-analysis of randomized trials. ( Abdi, A; Kalafat, E; Khalil, A; Sukur, YE; Thilaganathan, B, 2018)
" As with other oral hypoglycemics, the use of glyburide in pregnancy has been limited by fears of neonatal hypoglycemia following fetal exposure."8.84Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes. ( Koren, G; Moretti, ME; Rezvani, M, 2008)
"Use of glyburide in gestational diabetes (GDM) has raised concerns about fetal and neonatal side effects, including increased birth weight."7.85Glyburide treatment in gestational diabetes is associated with increased placental glucose transporter 1 expression and higher birth weight. ( Barbour, LA; Díaz, P; Dimasuay, KG; Jang, B; Jansson, T; Koele-Schmidt, L; Powell, TL, 2017)
"Glyburide is thought to be safe for use during pregnancy for treatment of gestational diabetes mellitus (GDM)."7.81Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes. ( Benjamin, DK; Boggess, K; Brookhart, MA; Camelo Castillo, W; Jonsson Funk, M; Stürmer, T, 2015)
"Despite widespread use of glyburide to treat pregnancy-related hyperglycemia, the dosing regimen is based in large part on pharmacokinetic and pharmacodynamic studies in men and nonpregnant women."7.79A pharmacologic approach to the use of glyburide in pregnancy. ( Caritis, SN; Hebert, MF, 2013)
"To examine the effect of obesity on maternal and neonatal outcomes in women diagnosed with gestational diabetes mellitus (GDM) and managed with diet only, glyburide, or insulin."7.78The effect of maternal obesity on pregnancy outcomes of women with gestational diabetes controlled with diet only, glyburide, or insulin. ( Desch, C; Istwan, N; Joy, S; Rhea, D; Roman, A; Saltzman, D; Stanziano, G, 2012)
"We sought to investigate the association between glyburide dose, degree of severity in gestational diabetes mellitus (GDM), level of glycemic control, and pregnancy outcome in insulin- and glyburide-treated patients."7.73Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. ( Langer, O; Rosenn, B; Xenakis, EM; Yogev, Y, 2005)
"The purpose of this study was to identify characteristics that may predict failure of glyburide therapy for the management of A2 gestational diabetes, and to evaluate whether those that fail are at increased risk for adverse pregnancy outcomes."7.73Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes. ( Gaddipati, S; Rand, L; Rochon, M; Roth, L, 2006)
"Glyburide is an effective treatment for reaching glycaemic goals during pregnancy in women with GDM."5.41Glyburide therapy for gestational diabetes: Glycaemic control, maternal hypoglycaemia, and treatment failure. ( Affres, H; Bouchghoul, H; Bouyer, J; Coustols-Valat, M; Deruelle, P; Letourneau, A; Senat, MV, 2021)
"Hypoglycemia was defined as a blood glucose of less than 50 mg/dL, further classified as "severe hypoglycemia" if the event required the assistance of another person for resuscitation, "symptomatic hypoglycemia" if it was associated with typical neurogenic symptoms, or "asymptomatic hypoglycemia" if the biochemical reading was less than 50 mg/dL with no symptoms or accompanied by mild symptoms that did not impair the patient's ability to function."5.37Hypoglycemia in glyburide-treated gestational diabetes: is it dose-dependent? ( Brustman, L; El Daouk, M; Fuchs, A; Langer, O; Rosenn, B; Scarpelli, S, 2011)
" The relationships between glyburide concentration and the time since the last intake of glyburide and between fetal glyburide concentration and neonatal hypoglycemia were modeled with linear or logistic regressions using fractional polynomials."5.34Transplacental transfer of glyburide in women with gestational diabetes and neonatal hypoglycemia risk. ( Alvarez, JC; Bouchghoul, H; Bouyer, J; Senat, MV; Verstuyft, C, 2020)
"An evaluation of 82 patients with gestational diabetes was performed; 30 were insulin-treated, 27 were managed by diet only, and 25 were patients treated with glyburide."5.32Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. ( Ben-Haroush, A; Chen, R; Hod, M; Langer, O; Rosenn, B; Yogev, Y, 2004)
"To evaluate whether the addition of glyburide to diet therapy modifies pregnancy outcomes in women with mild gestational diabetes."5.20Glyburide in Women With Mild Gestational Diabetes: A Randomized Controlled Trial. ( Abbassi-Ghanavati, M; Casey, BM; Duryea, EL; Leveno, KJ; McIntire, DD; Shivvers, SA; Tudela, CM, 2015)
"The only significant difference in outcome between the 2 treatment drugs was that maternal weight gain during pregnancy was less in the metformin (n=40) than in the glyburide group (n=32) (10."5.14Metformin compared with glyburide for the management of gestational diabetes. ( Bertini, AM; Bizato, J; de Souza, BV; Pacheco, C; Ribeiro, TE; Silva, JC, 2010)
"This review study of available literature shows that metformin can be a superior option in most neonatal and maternal adverse pregnancy outcomes in women with gestational diabetes mellitus; the results need to be further updated by including future more qualified studies."5.12Effectiveness of antidiabetic agents for treatment of gestational diabetes: A methodological quality assessment of meta-analyses and network meta-analysis. ( Amiri, M; Behboudi-Gandevani, S; Bidhendi Yarandi, R; Ramezani Tehrani, F, 2021)
"Metformin has been reported to reduce the risk of pre-eclampsia."4.98Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta-analysis of randomized trials. ( Abdi, A; Kalafat, E; Khalil, A; Sukur, YE; Thilaganathan, B, 2018)
"The use of metformin and glyburide in pregnancy for treatment of GDM has dramatically increased since the early 2000s."4.98Oral Agents for the Treatment of Gestational Diabetes. ( Finneran, MM; Landon, MB, 2018)
" Glyburide significantly increased the risk of any neonatal hypoglycemia [risk ratio (RR), 1."4.95Comparison of glyburide and insulin in the management of gestational diabetes: A meta-analysis. ( Chen, L; Chen, Y; Feng, W; Irwin, DM; Liu, Y; Si, X; Song, R, 2017)
"Our study concluded that metformin is fastest in glucose control, with a more favorable pregnancy outcomes-would be a better option, but its rate of glucose control is the lowest."4.95Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis. ( Liang, HL; Ma, SJ; Tan, HZ; Xiao, YN, 2017)
"Our study suggested that in women with GDM, glyburide is as effective as insulin, but the risks of neonatal hypoglycemia, high fetal birth weight, and macrosomia were higher."4.90The use of glyburide in the management of gestational diabetes mellitus: a meta-analysis. ( Chen, Y; Jiang, L; Li, BY; Li, MJ; Mo, XL; Wang, SM; Zeng, YC, 2014)
" Research suggests that glyburide and metformin can each effectively manage hyperglycemia in pregnancy."4.89Oral agents for the management of gestational diabetes. ( Berggren, EK; Boggess, KA, 2013)
"Available evidence supports the use of glyburide during pregnancy."4.84Pharmacological management of gestational diabetes: an overview. ( Coustan, DR, 2007)
" As with other oral hypoglycemics, the use of glyburide in pregnancy has been limited by fears of neonatal hypoglycemia following fetal exposure."4.84Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes. ( Koren, G; Moretti, ME; Rezvani, M, 2008)
" Average infant birth weight may be lower in mothers treated with insulin than with glyburide."4.84Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes. ( Baptiste-Roberts, K; Barone, BB; Bass, EB; Bennett, WL; Bolen, S; Gary, TL; Golden, SH; Neale, DM; Nicholson, WK; Wilson, LM; Witkop, CT, 2008)
"4%) had at least one episode of hypoglycemia, most often in the setting of glyburide."4.12Antenatal maternal hypoglycemia in women with gestational diabetes mellitus and neonatal outcomes. ( Cruz, M; Davitt, C; Harrison, RK; Palatnik, A; Saravanan, V, 2022)
"Time-varying exposure to glyburide vs insulin during pregnancy."4.12Association of Glyburide and Subcutaneous Insulin With Perinatal Complications Among Women With Gestational Diabetes. ( Badon, SE; Ferrara, A; Hedderson, MM; Neugebauer, R; Pimentel, N; Regenstein, A; Xu, F, 2022)
"Metformin is beneficial for GDM women to control total GWG compared with insulin, regulate fetal birth weight more than insulin and glyburide, and increase the risk of unmet treatment targets compared with insulin."4.12Efficacy and safety of hypoglycemic agents on gestational diabetes mellitus in women: A Bayesian network analysis of randomized controlled trials. ( Chen, H; Cui, W; Guo, H; Huang, L; Jing, Y; Liu, X; Song, L; Sun, B; Wang, M; Wang, N; Wang, T; Xu, J, 2022)
"Use of glyburide in gestational diabetes (GDM) has raised concerns about fetal and neonatal side effects, including increased birth weight."3.85Glyburide treatment in gestational diabetes is associated with increased placental glucose transporter 1 expression and higher birth weight. ( Barbour, LA; Díaz, P; Dimasuay, KG; Jang, B; Jansson, T; Koele-Schmidt, L; Powell, TL, 2017)
"To evaluate treatment effectiveness (diet alone, insulin or glyburide) on maternal weight gain in gestational diabetes (GDM)."3.83Weight gain in gestational diabetes: the effect of treatment modality. ( Bimson, B; Brustman, LE; El Daouk, M; Langer, O; Scarpelli, S, 2016)
"The 5 mg/day glyburide dose did not increase maternal hypoglycemia (26% in the 2."3.83Examining the Starting Dose of Glyburide in Gestational Diabetes. ( Biggio, JR; Glover, AV; Harper, LM; Tita, A, 2016)
"To evaluate the safety, efficacy and pregnancy outcomes of insulin detemir (IDet) versus glyburide treatment in women with gestational diabetes mellitus (GDM)."3.83Insulin detemir versus glyburide in women with gestational diabetes mellitus. ( Ashwal, E; Hod, M; Koren, R; Toledano, Y, 2016)
"Glyburide is thought to be safe for use during pregnancy for treatment of gestational diabetes mellitus (GDM)."3.81Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes. ( Benjamin, DK; Boggess, K; Brookhart, MA; Camelo Castillo, W; Jonsson Funk, M; Stürmer, T, 2015)
"Our PBPK model integrating prior physiological knowledge, in vitro and in vivo data, allowed successful prediction of methadone and glyburide disposition during pregnancy."3.80Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19. ( Ke, AB; Nallani, SC; Rostami-Hodjegan, A; Unadkat, JD; Zhao, P, 2014)
"Despite widespread use of glyburide to treat pregnancy-related hyperglycemia, the dosing regimen is based in large part on pharmacokinetic and pharmacodynamic studies in men and nonpregnant women."3.79A pharmacologic approach to the use of glyburide in pregnancy. ( Caritis, SN; Hebert, MF, 2013)
"Neonatal chemical hypoglycemia occurs more frequently in infants from women with type 2 diabetes and GDM treated with glyburide or insulin."3.78Neonatal chemical hypoglycemia in newborns from pregnancies complicated by type 2 and gestational diabetes mellitus - the importance of neonatal ponderal index. ( Aguayo, J; Hanley, AA; Kim, JH; Moore, TR; Ramos, GA; Warshak, CR, 2012)
"To examine the effect of obesity on maternal and neonatal outcomes in women diagnosed with gestational diabetes mellitus (GDM) and managed with diet only, glyburide, or insulin."3.78The effect of maternal obesity on pregnancy outcomes of women with gestational diabetes controlled with diet only, glyburide, or insulin. ( Desch, C; Istwan, N; Joy, S; Rhea, D; Roman, A; Saltzman, D; Stanziano, G, 2012)
"This article discusses a retrospective study of 8,711 women, delivering at ≥ 20 weeks' gestation, who had a prenatal 2-h 75-g OGTT without a prior 50-g challenge and were not treated with insulin, glyburide, diet, and/or exercise during pregnancy."3.76Clinical outcomes of pregnancies complicated by mild gestational diabetes mellitus differ by combinations of abnormal oral glucose tolerance test values. ( Black, MH; Lawrence, JM; Sacks, DA; Xiang, AH, 2010)
"We sought to investigate the association between glyburide dose, degree of severity in gestational diabetes mellitus (GDM), level of glycemic control, and pregnancy outcome in insulin- and glyburide-treated patients."3.73Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. ( Langer, O; Rosenn, B; Xenakis, EM; Yogev, Y, 2005)
"In a large managed care organization, glyburide was at least as effective as insulin in achieving glycemic control and similar birth weights in women with GDM who failed diet therapy."3.73Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. ( Ching, JY; Ferrara, A; Field, DR; Jacobson, GF; Kirby, RS; Ramos, GA, 2005)
"This is the first direct evidence of active glyburide transport from the fetus to the mother and, in general, of any medicinal drug used during pregnancy."3.73Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. ( Klein, J; Koren, G; Kraemer, J; Lubetsky, A, 2006)
"Glyburide was more likely to fail in women diagnosed earlier in pregnancy, of older age and multiparity, and with higher fasting glucoses, suggesting that earlier glucose intolerance and a reduced capacity to respond to an insulin secretagogue may distinguish this group."3.73Predictors of glyburide failure in the treatment of gestational diabetes. ( Barbour, LA; Davies, JK; Kahn, BF; Lynch, AM; Reynolds, RM, 2006)
"The purpose of this study was to identify characteristics that may predict failure of glyburide therapy for the management of A2 gestational diabetes, and to evaluate whether those that fail are at increased risk for adverse pregnancy outcomes."3.73Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes. ( Gaddipati, S; Rand, L; Rochon, M; Roth, L, 2006)
"Persons with gestational and pregestational diabetes during pregnancy may require pharmacologic agents to achieve pregnancy glycemic targets, and the available medications for use in pregnancy are limited."3.01Medications for Managing Preexisting and Gestational Diabetes in Pregnancy. ( Caughey, AB; Rickert, M; Valent, AM, 2023)
" Data are limited regarding the pharmacodynamic effects of metformin and glyburide during pregnancy."2.94Pharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin Combination Therapy in the Treatment of Gestational Diabetes Mellitus. ( Ahmed, MS; Brown, LM; Brown, Z; Caritis, S; Clark, S; Easterling, TR; Flood Nichols, SK; Haas, DM; Haneline, LS; Hebert, MF; Ma, X; Manuck, TA; Quinney, SK; Ren, Z; Shen, DD; Shireman, LM; Shuster, DL; Thummel, KE; Tita, AT; Venkataramanan, R, 2020)
"In women with gestational diabetes mellitus (GDM) requiring pharmacotherapy, insulin was the established first-line treatment."2.90SUGAR-DIP trial: oral medication strategy versus insulin for diabetes in pregnancy, study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial. ( Akerboom, BMC; Assouiki, F; Bosmans, JE; Braams-Lisman, BAM; Brouwer, CB; Daemen-Gubbels, CRGM; de Boer, K; de Galan, BE; de Koning, EJP; de Valk, HW; de Wit, L; deVries, JH; Diekman, MJM; Dullemond, RC; Eskes, SA; Evers, IM; Franx, A; Galjaard, S; Gallas, PRJ; Groenendaal, F; Heijligenberg, R; Hermes, W; Hermsen, BB; Horree, N; Huisjes, AJM; IJzerman, RG; Jansen, HJ; Kiewiet-Kemper, RM; Klooker, TK; Kuppens, SMI; Laan, R; Mensing van Charante, NA; Mol, BW; Naaktgeboren, CA; Oosterwerff, MM; Painter, RC; Potter van Loon, BJ; Rademaker, D; Sanson-van Praag, ME; Schippers, DH; Soeters, MR; Sueters, M; van Bemmel, T; van Bon, AC; van den Akker, ES; van den Beld, AW; van der Heijden, OWH; van der Made, FW; van Houtum, WH; van Laar, JOEH; van Leeuwen, M; van Meir, CA; van Rijn, BB; Veldhuis-Vlug, AG; Vermeulen, MAR; Verwij-Didden, MAL; Vidarsdottir, S; Visser, W; Vogelvang, TE; Voormolen, DN; Wijbenga, JAM; Wouters, MGAJ; Wouters-van Poppel, P; Zandstra, M; Zwart, JJ; Zwertbroek, R, 2019)
" The starting dosage for glyburide was 2."2.87Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial. ( Affres, H; Beucher, G; Bourcigaux, N; Bouyer, J; Bretelle, F; Castera, V; Cazaubiel, M; Coustols-Valat, M; De Carne, C; Deruelle, P; Desbriere, R; Héron, I; Jacquier, JF; Laboureau, S; Legardeur, H; Letourneau, A; Maillot, F; Mitanchez, D; Morin, M; Rod, A; Rolland, C; Sénat, MV; Sentilhes, L; Simon, E; Verspyck, E, 2018)
"Metformin is widely used to treat gestational diabetes (GDM), but many women remain hyperglycaemic and require additional therapy."2.84Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial. ( Alexander, CI; Bell, JL; Denison, FC; Juszczak, E; Lindsay, RS; Love, CDB; Mackenzie, F; Norman, JE; Penneycard, J; Reynolds, RM; Stenson, B; Strachan, MWJ; Whyte, S, 2017)
"Glyburide was started in 53 patients and metformin in 51."2.84Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. ( Gam Ze Letova, Y; Hasanein, J; Hissin, N; Nachum, Z; Salim, R; Suleiman, A; Yefet, E; Zafran, N, 2017)
"Oral hypoglycemic drugs for the treatment of gestational diabetes mellitus (GDM) are still controversial because they can pass through the placenta."2.82Comparison of the effectiveness and safety of insulin and oral hypoglycemic drugs in the treatment of gestational diabetes mellitus: a meta-analysis of 26 randomized controlled trials. ( Gao, C; Jia, X; Li, C; Shi, H; Zhang, L; Zhang, X, 2022)
"In a south Indian population with gestational diabetes, metformin was associated with better neonatal outcomes than glibenclamide."2.80Comparison of neonatal outcomes in women with gestational diabetes with moderate hyperglycaemia on metformin or glibenclamide--a randomised controlled trial. ( Abraham, A; Antonisamy, B; Beck, M; Benjamin, SJ; George, A; Jana, AK; Mathews, JE; Sam, D; Thomas, N, 2015)
"Women with gestational diabetes mellitus were randomly allocated to two insulin and glyburide groups and compared with maternal and neonatal outcome."2.80Comparison of glyburide and insulin in women with gestational diabetes mellitus and associated perinatal outcome: a randomized clinical trial. ( Faalpoor, Z; Heidar, Z; Jamali, R; Mirzamoradi, M; Naeiji, Z, 2015)
"Glyburide was found to be as efficacious as insulin in achieving euglycemia in the treatment of gestational diabetic women who require treatment beyond diet control."2.78Glyburide as treatment option for gestational diabetes mellitus. ( Mayanglambam, RD; Tempe, A, 2013)
"Patients with gestational diabetes who did not achieve glycemic control on diet were randomly assigned to metformin (n=75) or glyburide (n=74) as single agents."2.75Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. ( Clokey, D; Curet, LB; Moore, LE; Rappaport, VJ, 2010)
" Women with GDM in whom glyburide treatment has failed may benefit from alternative medication or dosage escalation; however, fetal safety should be kept in mind."2.74Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. ( Ahmed, MS; Blough, D; Caritis, SN; Carr, DB; Cobelli, C; Easterling, TR; Hankins, GD; Hebert, MF; Kelly, EJ; Krudys, KM; Ma, X; Mattison, DR; Miodovnik, M; Naraharisetti, SB; Snodgrass, WR; Umans, JG; Unadkat, JD; Vicini, P, 2009)
"To study glibenclamide as a treatment for gestational diabetes mellitus (GDM) and its impact on newborn birth weight and neonatal glycemia as compared to insulin."2.73[Glibenclamide in the treatment for gestational diabetes mellitus in a compared study to insulin]. ( Aquim, GM; Bebber, FR; Becker, F; Bertini, AM; Silva, JC; Taborda, W; Viesi, JM, 2007)
"The comparative efficacy of gestational diabetes (GDM) treatments lack conclusive evidence for choice of first-line treatment."2.72Metformin is comparable to insulin for pharmacotherapy in gestational diabetes mellitus: A network meta-analysis evaluating 6046 women. ( Abou-Samra, AB; Bashir, M; Chivese, T; Clark, J; Doi, SA; Furuya-Kanamori, L; Mohamed, AM; Musa, OAH; Syed, A; Thalib, L; Toft, E; Xu, C, 2021)
"Maternal gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy, which can adversely affect the short- and long-term health of mothers and newborns."2.72Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options. ( Brunetti, A; Chiefari, E; Foti, D; Greco, E; Mirabelli, M; Tocci, V, 2021)
"Neonatal hypoglycemia was observed in eight newborns, six of which from the glyburide group."2.71Perinatal outcomes and the use of oral hypoglycemic agents. ( Aquim, G; Becker, F; Bertini, AM; Engel Ribeiro, T; Lemos Bebber, FR; Silva, JC; Taborda, W; Zucco Viesi, JM, 2005)
"Women with gestational diabetes mellitus are rarely treated with a sulfonylurea drug, because of concern about teratogenicity and neonatal hypoglycemia."2.69A comparison of glyburide and insulin in women with gestational diabetes mellitus. ( Berkus, MD; Conway, DL; Gonzales, O; Langer, O; Xenakis, EM, 2000)
"Fetal growth in gestational diabetes mellitus (GDM) is directly linked to maternal glycaemic control; however, this relationship may be altered by oral anti-hyperglycaemic agents."2.66Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: A systematic review and meta-analysis. ( Aiken, CE; Ozanne, SE; Tarry-Adkins, JL, 2020)
"Glyburide has been associated with increased neonatal hypoglycemia."2.61The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy. ( Blair, RA; Palermo, NE; Rosenberg, EA, 2019)
"Pregestational and gestational diabetes are associated with significant maternal and fetal risks; therefore, screening and treatment during pregnancy are recommended."2.61Pharmacologic Treatment of Diabetes in Pregnancy. ( Bishop, KC; Boyd, BK; Brown, L; Harris, BS; Kuller, JA; Reiff, ES, 2019)
"Metformin has also proven to be safe and may be considered as an initial single agent for milder gestational diabetes."2.55The care of pregestational and gestational diabetes and drug metabolism considerations. ( Davis, SN; Hedrington, MS, 2017)
"Glyburide has good efficacy and short-term data but it also crosses the placenta and may be associated with increased rates of large-for-gestational-age (LGA) infants and neonatal hypoglycaemia when compared with insulin."2.55Pharmacological Management of Gestational Diabetes Mellitus. ( Feig, DS; Mukerji, G, 2017)
" In areas of limited resources where the self-monitoring needed for accurate insulin dosing is not possible, where access to refrigeration for insulin storage is not universal, or severe needle phobia then the benefits of glyburide (controlling hyperglycemia) outweighs the harm of NICU admissions and macrosomia."2.53Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus. ( Davis, SN; Malek, R, 2016)
"The primary aims of the treatment of gestational diabetes (GDM) are to prevent macrosomia and pregnancy complications."2.53Is it worth treating gestational diabetes: if so, when and how? ( Vääräsmäki, M, 2016)
" Other oral medications have not been shown to be safe in pregnancy."2.52Safety considerations with pharmacological treatment of gestational diabetes mellitus. ( Simmons, D, 2015)
"At short term, in women with gestational diabetes requiring drug treatment, glibenclamide is clearly inferior to both insulin and metformin, while metformin (plus insulin when required) performs slightly better than insulin."2.52Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. ( Balsells, M; Corcoy, R; García-Patterson, A; Gich, I; Roqué, M; Solà, I, 2015)
"Metformin seems to be a superior choice to glyburide if oral antidiabetic drug therapy is to be initiated in GDM patients."2.52Comparison of glyburide with metformin in treating gestational diabetes mellitus: a systematic review and meta-analysis. ( Amin, M; Malik, O; Poolsup, N; Suksomboon, N, 2015)
"Metformin seems to be an efficacious alternative to insulin and a better choice than glyburide especially those with mild form of disease."2.50Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: a meta-analysis. ( Amin, M; Poolsup, N; Suksomboon, N, 2014)
" In this article, we review the efficacy, safety, and dosage of oral hypoglycemic agents for the treatment of gestational diabetes mellitus."2.50Gestational diabetes mellitus management with oral hypoglycemic agents. ( Hays, KE; Hebert, MF; Ryu, RJ, 2014)
"Pregnancy is an indication for intensive insulin therapy."2.48[Drug therapy for diabetes mellitus during pregnancy and breastfeeding in the beginning of 21 century: status quo and new challenges]. ( Zhelyazkova-Savova, M, 2012)
" In this review, our objectives were to (1) summarise the available evidence on the efficacy these medications, (2) review available data on adverse effect, (3) discuss current gaps in research, outlining limitations in current study designs that deserve attention and (4) summarise key points for the practicing clinician."2.47Oral hypoglycaemic agents during pregnancy: The evidence for effectiveness and safety. ( Baptiste-Roberts, K; Nicholson, W, 2011)
"For patients with Type 2 diabetes or gestational diabetes, oral hypoglycemic agents (OHAs) represent an attractive alternative to insulin therapy."2.46Oral hypoglycemic therapy: understanding the mechanisms of transplacental transfer. ( Feig, DS; Koren, G; Pollex, EK, 2010)
"Women with type 2 diabetes treated with sulfonylureas should not be discouraged from breastfeeding."2.45Use of hypoglycemic drugs during lactation. ( Djokanovic, N; Finkelstein, Y; Garcia-Bournissen, F; Glatstein, MM; Koren, G, 2009)
"The incidence of gestational diabetes is increasing."2.45The management of gestational diabetes. ( Cheung, NW, 2009)
"Maternal characteristics and outcomes (preeclampsia and weight gain) and neonatal outcomes (birth weight and percentile, hypoglycemia, jaundice, and respiratory morbidity) were compared between groups."1.91Insulin Detemir Versus Glibenclamide in Gestational Diabetes Mellitus: A Retrospective Cohort Study. ( Fakterman, M; Kovo, M; Leytes, S; Ravid, D; Weitzner, O; Yagur, Y, 2023)
"The increased prevalence of gestational diabetes mellitus (GDM) has caused a huge societal economic and healthy burden at both the population and individual levels."1.72Comparative efficacy and safety of glyburide, metformin, and insulin in treatment of gestational diabetes mellitus: A protocol for systematic review and meta-analysis. ( Hong, XY; Lin, J; Tu, RZ, 2022)
"In addition, the steps in the gestational diabetes mellitus management decision path and the current cost of the use of insulin, glyburide, or metformin are addressed."1.48Pharmacological treatment of gestational diabetes mellitus: point/counterpoint. ( Langer, O, 2018)
"Successful rat models for preeclampsia were confirmed based on mean arterial pressure, a 24-h protein urine test, and by observing the structure of the kidney by transmission electron microscopy (TEM)."1.48Role of AKR1C3 in renal injury and glibenclamide is anti-inflammatory in preeclamptic rats. ( Jin, Y; Li, L; Liu, XW; Sun, CJ; Zhang, WY, 2018)
"Glyburide failure was defined as reaching glyburide 20 mg day(-1) and receiving insulin."1.43Predicting failure of glyburide therapy in gestational diabetes. ( Biggio, JR; Glover, AV; Harper, LM; Tita, A, 2016)
"Maternal obesity and gestational diabetes mellitus (GDM) are two increasingly common and important obstetric complications that are associated with severe long-term health risks to mothers and babies."1.42Endoplasmic reticulum stress is increased in adipose tissue of women with gestational diabetes. ( Lappas, M; Liong, S, 2015)
"Glyburide has replaced insulin as the more common pharmacotherapy for GDM over the past decade among those privately insured."1.40Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011. ( Benjamin, DK; Boggess, K; Brookhart, MA; Camelo Castillo, W; Jonsson Funk, M; Stürmer, T, 2014)
"Glyburide (200 ng/mL) was introduced to maternal and fetal compartments through a recirculating 2 hour perfusion, and its transplacental transport was tested with (n = 8) or without (n = 8) cannabidoil."1.39Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study. ( Ben-Zvi, Z; Erez, O; Eshkoli, T; Feinshtein, V; Holcberg, G; Sheiner, E; Sheizaf, B, 2013)
"Neonates born to women with gestational diabetes managed on glyburide, and were more likely to be macrosomic and to be admitted to the intensive care unit compared to those treated with insulin injections."1.38Treatment of gestational diabetes mellitus: glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes. ( Block-Kurbisch, I; Caughey, AB; Cheng, YW; Chung, JH; Inturrisi, M, 2012)
"Hypoglycemia was defined as a blood glucose of less than 50 mg/dL, further classified as "severe hypoglycemia" if the event required the assistance of another person for resuscitation, "symptomatic hypoglycemia" if it was associated with typical neurogenic symptoms, or "asymptomatic hypoglycemia" if the biochemical reading was less than 50 mg/dL with no symptoms or accompanied by mild symptoms that did not impair the patient's ability to function."1.37Hypoglycemia in glyburide-treated gestational diabetes: is it dose-dependent? ( Brustman, L; El Daouk, M; Fuchs, A; Langer, O; Rosenn, B; Scarpelli, S, 2011)
"Glyburide and metformin have been shown to be as effective as insulin for the treatment of gestational diabetes."1.37Oral hypoglycemic agents in pregnancy. ( Refuerzo, JS, 2011)
"Hyperlipidemia occurs in GDM."1.36Impact of hyperlipidemia on plasma protein binding and hepatic drug transporter and metabolic enzyme regulation in a rat model of gestational diabetes. ( Anger, GJ; Piquette-Miller, M, 2010)
"Glyburide was transported by multidrug resistance protein (43 +/- 4%); breast cancer resistance protein (25 +/- 5%); and P-glycoprotein (9 +/- 5%)."1.36Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. ( Ahmed, MS; Hankins, GD; Hemauer, SJ; Nanovskaya, TN; Patrikeeva, SL, 2010)
"Glyburide (GLB) is an oral sulfonylurea, commonly used for the treatment of gestational diabetes mellitus."1.36Increased glyburide clearance in the pregnant mouse model. ( Hebert, MF; Mao, Q; Unadkat, JD; Zhang, Y; Zhou, L, 2010)
"Glyburide, a drug used to treat gestational diabetes has previously been shown not to be measurable in fetal blood, and to be transferred from the fetal to the maternal circulation against a concentration gradient."1.35Investigating the potential role of multi-drug resistance protein (MRP) transporters in fetal to maternal glyburide efflux in the human placenta. ( Anger, G; Gedeon, C; Koren, G; Lubetsky, A; Miller, MP, 2008)
" However, by means of pharmacokinetic modeling we describe the inverse correlation between lipid solubility of a molecule and its active transport by placental ABC efflux transporters."1.35Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility. ( Ceckova, M; Cygalova, LH; Hofman, J; Staud, F, 2009)
"Treatment of gestational diabetes mellitus is a hotly debated topic."1.35[Oral blood glucose-lowering medication as a monotherapy in gestational diabetes: a hotly debated topic]. ( de Valk, HW, 2009)
"Glyburide was detected at 254 nm, with a total run time of 7 min per sample."1.35A simple and rapid HPLC method for the detection of glyburide in plasma original research communication (analytical). ( Aleksa, K; Gedeon, C; Kapur, B; Koren, G, 2008)
"Glyburide (GLB) is an antidiabetic drug routinely used to treat gestational diabetes."1.35The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. ( Hebert, MF; Mao, Q; Naraharisetti, SB; Unadkat, JD; Wang, H; Zhou, L, 2008)
"Glyburide is a second-generation sulfonylurea hypoglycemic drug used for the treatment of select women with pregestational and gestational diabetes mellitus (GDM)."1.33Effect of human serum albumin on transplacental transfer of glyburide. ( Ahmed, MS; Hankins, GD; Nanovskaya, TN; Nekhayeva, I, 2006)
"The glyburide failure rate was calculated and factors that might predict success with glyburide were analyzed between the success and failure groups using chi(2) or Student'st-tests."1.32Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. ( Chmait, R; Dinise, T; Moore, T, 2004)
"Approximately 80% of patients with gestational diabetes who fail to respond to diet therapy can be treated effectively with glyburide."1.32Glyburide for the treatment of gestational diabetes. ( Duff, P; Kremer, CJ, 2004)
"An evaluation of 82 patients with gestational diabetes was performed; 30 were insulin-treated, 27 were managed by diet only, and 25 were patients treated with glyburide."1.32Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. ( Ben-Haroush, A; Chen, R; Hod, M; Langer, O; Rosenn, B; Yogev, Y, 2004)
"Quite a few of my patients experience gestational diabetes."1.32Breakthrough in treating gestational diabetes mellitus. ( Koren, G, 2004)
"Sevoflurane responses were repeated at concentrations with no effect on spontaneous contractility of TEA, a Ca(2+)-activated K(+) channel blocker, and glibenclamide, an adenosine triphosphate-sensitive K(+) channel blocker, in myometrial strips."1.31The role of K(+) channels on the inhibitor effect of sevoflurane in pregnant rat myometrium. ( Bagcivan, I; Gürsoy, S; Kafali, H; Karadas, B; Kaya, T; Sarioglu, Y, 2002)
"The pregnancy outcome of 33 women with gestational diabetes who were treated with glibenclamide and changed to insulin if glibenclamide failed, were compared with the pregnancy outcome of 21 women with gestational diabetes treated conventionally with insulin."1.30A comparison between the pregnancy outcome of women with gestation diabetes treated with glibenclamide and those treated with insulin. ( Lim, JM; O'Brien, PM; Shaw, RW; Tayob, Y, 1997)
"Aprikalim and BRL 38227 were also potent relaxants of oxytocin (1 nmol/L)-induced contractions with rapid onset of action, of similar potency to each other, and reversible."1.29Inhibition of contractions of the isolated human myometrium by potassium channel openers. ( Cheuk, JM; Hollingsworth, M; Hughes, SJ; Maresh, MJ; Piper, IT, 1993)

Research

Studies (252)

TimeframeStudies, this research(%)All Research%
pre-199011 (4.37)18.7374
1990's22 (8.73)18.2507
2000's81 (32.14)29.6817
2010's106 (42.06)24.3611
2020's32 (12.70)2.80

Authors

AuthorsStudies
Venkatesh, KK1
Chiang, CW1
Castillo, WC2
Battarbee, AN1
Donneyong, M1
Harper, LM3
Costantine, M1
Saade, G1
Werner, EF1
Boggess, KA2
Landon, MB3
Yu, DQ1
Xu, GX1
Teng, XY1
Xu, JW1
Tang, LF1
Feng, C1
Rao, JP1
Jin, M1
Wang, LQ1
Wang, C1
Ma, D1
Hua, Y1
Duan, H1
Palatnik, A2
Harrison, RK2
Thakkar, MY1
Walker, RJ1
Egede, LE1
Li, C2
Gao, C1
Zhang, X2
Zhang, L1
Shi, H1
Jia, X1
Paventi, G1
Soldovieri, MV1
Servettini, I1
Barrese, V1
Miceli, F1
Sisalli, MJ1
Ambrosino, P1
Mosca, I1
Vinciguerra, I1
Testai, L1
Scorziello, A1
Raimo, G1
Calderone, V1
Passarella, S1
Taglialatela, M1
Saravanan, V1
Davitt, C1
Cruz, M1
Oliveira, MM1
Andrade, KFO1
Lima, GHS1
Rocha, TC1
Lin, J1
Tu, RZ1
Hong, XY1
Hedderson, MM1
Badon, SE1
Pimentel, N1
Xu, F1
Regenstein, A1
Ferrara, A2
Neugebauer, R1
Mehta, D1
Li, M1
Nakamura, N1
Chidambaram, M1
He, X1
Bryant, MS1
Patton, R1
Davis, K1
Fisher, J1
Walton-Betancourth, S1
Ashford, J1
Beardsall, K1
Gooding, N1
Gurnell, EM1
Hendriks, E1
Hysted, H1
Lee, J2
Thankamony, A1
Tseretopoulou, X1
Win, M1
Williams, RM1
Pilszyk, A1
Niebrzydowska, M1
Pilszyk, Z1
Wierzchowska-Opoka, M1
Kimber-Trojnar, Ż2
Wang, T1
Jing, Y1
Guo, H1
Xu, J1
Wang, M1
Huang, L1
Chen, H2
Cui, W1
Song, L1
Liu, X1
Sun, B1
Wang, N1
Rickert, M1
Caughey, AB4
Valent, AM1
Prozorova, TM1
Zhulkevych, IV1
Andreychyn, SM1
Korylchuk, NI1
Hanberher, II1
Riabokon, SS1
Kamyshnyi, AM1
Ravid, D1
Kovo, M1
Leytes, S1
Yagur, Y1
Fakterman, M1
Weitzner, O1
de Wit, L1
Rademaker, D1
Voormolen, DN1
Akerboom, BMC1
Kiewiet-Kemper, RM1
Soeters, MR1
Verwij-Didden, MAL1
Assouiki, F1
Schippers, DH1
Vermeulen, MAR1
Kuppens, SMI1
Oosterwerff, MM1
Zwart, JJ1
Diekman, MJM1
Vogelvang, TE1
Gallas, PRJ1
Galjaard, S1
Visser, W1
Horree, N1
Klooker, TK1
Laan, R1
Heijligenberg, R1
Huisjes, AJM1
van Bemmel, T1
van Meir, CA1
van den Beld, AW1
Hermes, W1
Vidarsdottir, S1
Veldhuis-Vlug, AG1
Dullemond, RC1
Jansen, HJ1
Sueters, M1
de Koning, EJP1
van Laar, JOEH1
Wouters-van Poppel, P1
Sanson-van Praag, ME1
van den Akker, ES1
Brouwer, CB1
Hermsen, BB1
Potter van Loon, BJ1
van der Heijden, OWH1
de Galan, BE1
van Leeuwen, M1
Wijbenga, JAM1
de Boer, K1
van Bon, AC1
van der Made, FW1
Eskes, SA1
Zandstra, M1
van Houtum, WH1
Braams-Lisman, BAM1
Daemen-Gubbels, CRGM1
Wouters, MGAJ1
IJzerman, RG1
Mensing van Charante, NA1
Zwertbroek, R1
Bosmans, JE1
Evers, IM1
Mol, BW1
de Valk, HW2
Groenendaal, F1
Naaktgeboren, CA1
Painter, RC1
deVries, JH1
Franx, A1
van Rijn, BB1
Mott, K1
Reichman, ME1
Toh, S1
Kieswetter, C1
Haffenreffer, K1
Andrade, SE1
Guo, L1
Ma, J1
Tang, J2
Hu, D1
Zhang, W1
Zhao, X1
Blair, RA1
Rosenberg, EA1
Palermo, NE1
Shuster, DL2
Shireman, LM1
Ma, X2
Shen, DD2
Flood Nichols, SK1
Ahmed, MS9
Clark, S1
Caritis, S2
Venkataramanan, R1
Haas, DM1
Quinney, SK1
Haneline, LS1
Tita, AT1
Manuck, TA1
Thummel, KE2
Brown, LM1
Ren, Z1
Brown, Z1
Easterling, TR3
Hebert, MF8
Helal, KF1
Badr, MS1
Rafeek, ME1
Elnagar, WM1
Lashin, ME1
Lawal, SK1
Adeniji, AA1
Sulaiman, SO1
Akajewole, MM1
Buhari, MO1
Osinubi, AA1
Bouchghoul, H3
Alvarez, JC1
Verstuyft, C2
Bouyer, J5
Senat, MV5
Tarry-Adkins, JL1
Aiken, CE1
Ozanne, SE1
Lofthouse, EM1
Cleal, JK1
Hudson, G1
Lewis, RM1
Sengers, BG1
Stanik, J1
Barak, L1
Dankovcikova, A1
Valkovicova, T1
Skopkova, M1
Gasperikova, D1
Krispin, E1
Ashkenazi Katz, A1
Shmuel, E1
Toledano, Y3
Hadar, E2
Feghali, M1
Atlass, J1
Abebe, KZ1
Comer, D1
Catov, J1
Arslanian, S1
Scifres, C1
Affres, H3
Letourneau, A3
Deruelle, P2
Coustols-Valat, M2
Mandelbrot, L1
Bourcigaux, N2
Becquemont, L1
Chatzakis, C1
Cavoretto, P1
Sotiriadis, A1
Musa, OAH1
Syed, A1
Mohamed, AM1
Chivese, T1
Clark, J1
Furuya-Kanamori, L1
Xu, C1
Toft, E1
Bashir, M1
Abou-Samra, AB1
Thalib, L1
Doi, SA1
Wang, X2
Liu, W1
Chen, Q1
Bidhendi Yarandi, R1
Amiri, M1
Ramezani Tehrani, F1
Behboudi-Gandevani, S1
Mirabelli, M1
Chiefari, E1
Tocci, V1
Greco, E1
Foti, D1
Brunetti, A1
Farrar, D1
Simmonds, M1
Bryant, M1
Sheldon, TA1
Tuffnell, D1
Golder, S1
Lawlor, DA1
Barbour, LA4
Davies, JK2
Nachum, Z2
Yefet, E2
Song, R1
Chen, L1
Chen, Y2
Si, X1
Liu, Y2
Irwin, DM1
Feng, W1
Hedrington, MS1
Davis, SN2
Díaz, P1
Dimasuay, KG1
Koele-Schmidt, L1
Jang, B1
Jansson, T1
Powell, TL1
Mukerji, G1
Feig, DS2
Liang, HL1
Ma, SJ1
Xiao, YN1
Tan, HZ1
Reynolds, RM2
Denison, FC1
Juszczak, E1
Bell, JL1
Penneycard, J1
Strachan, MWJ1
Lindsay, RS1
Alexander, CI1
Love, CDB1
Whyte, S1
Mackenzie, F1
Stenson, B1
Norman, JE1
Gao, H2
Ho, E1
Balakrishnan, M1
Yechoor, V1
Yallampalli, C2
Tamura, K1
Ishikawa, G1
Yoshie, M1
Ohneda, W1
Nakai, A1
Takeshita, T1
Tachikawa, E1
Blundell, C1
Yi, YS1
Ma, L1
Tess, ER1
Farrell, MJ1
Georgescu, A1
Aleksunes, LM2
Huh, D1
Langer, O10
Sun, CJ1
Jin, Y1
Zhang, WY1
Li, L1
Liu, XW1
Coustan, DR3
Barbour, L1
Cazaubiel, M1
Legardeur, H1
Jacquier, JF1
Simon, E1
Rod, A1
Héron, I1
Castera, V1
Sentilhes, L1
Bretelle, F1
Rolland, C1
Morin, M1
De Carne, C1
Maillot, F1
Beucher, G1
Verspyck, E1
Desbriere, R1
Laboureau, S1
Mitanchez, D1
Kalafat, E1
Sukur, YE1
Abdi, A1
Thilaganathan, B1
Khalil, A1
Kautzky-Willer, A1
Harreiter, J1
Finneran, MM1
Peng, S1
Sun, X1
Bishop, KC1
Harris, BS1
Boyd, BK1
Reiff, ES1
Brown, L1
Kuller, JA1
Mathews, JE2
Biswas, B1
Samuel, P1
Jana, AK2
Muliyil, JP1
Mathai, M1
Tempe, A1
Mayanglambam, RD1
Caritis, SN3
Ke, AB1
Nallani, SC1
Zhao, P1
Rostami-Hodjegan, A1
Unadkat, JD5
Feinshtein, V1
Erez, O2
Ben-Zvi, Z1
Eshkoli, T1
Sheizaf, B1
Sheiner, E1
Holcberg, G1
Berggren, EK1
Gupta, Y2
Marciniak, B1
Patro-Malysza, J1
Skorzynska-Dziduszko, K1
Poniedzialek-Czajkowska, E1
Mierzynski, R1
Galczynski, K1
Trojnar, M1
Leszczynska-Gorzelak, B1
Oleszczuk, J1
Zeng, YC1
Li, MJ1
Jiang, L1
Wang, SM1
Mo, XL1
Li, BY1
Camelo Castillo, W2
Boggess, K2
Stürmer, T2
Brookhart, MA2
Benjamin, DK2
Jonsson Funk, M2
Risler, LJ1
Liang, CK1
Rice, KM1
Mao, Q3
Kalra, B1
Singla, R1
Kalra, S1
Vernikovskaya, DI1
Fokina, VM2
Nanovskaya, TN6
Hankins, GD8
Myngheer, N1
Allegaert, K1
Hattersley, A1
McDonald, T1
Kramer, H1
Ashcroft, FM1
Verhaeghe, J1
Mathieu, C1
Casteels, K1
Poolsup, N2
Suksomboon, N2
Amin, M2
Ryu, RJ1
Hays, KE1
Benhalima, K1
Devlieger, R1
Van Assche, A1
Simmons, D1
Sacks, DA2
Balsells, M1
García-Patterson, A1
Solà, I1
Roqué, M1
Gich, I1
Corcoy, R1
Buschur, E1
Brown, F1
Wyckoff, J1
George, A1
Sam, D1
Beck, M1
Benjamin, SJ1
Abraham, A1
Antonisamy, B1
Thomas, N1
Mirzamoradi, M1
Heidar, Z1
Faalpoor, Z1
Naeiji, Z1
Jamali, R1
Schwartz, RA1
Rosenn, B4
Aleksa, K2
Koren, G11
Jiang, YF1
Chen, XY1
Ding, T1
Wang, XF1
Zhu, ZN1
Su, SW1
Holt, RI2
Wise, J1
Liong, S1
Lappas, M1
Damm, P1
Mathiesen, ER1
Lovasz, N2
Koncz, A1
Domokos, D1
Gaspar, R2
Falkay, G2
Brustman, LE1
Bimson, B1
Scarpelli, S2
El Daouk, M2
Carroll, D1
Kelley, KW1
Malik, O1
Casey, BM1
Duryea, EL1
Abbassi-Ghanavati, M1
Tudela, CM1
Shivvers, SA1
McIntire, DD1
Leveno, KJ1
Glover, AV2
Tita, A2
Biggio, JR2
Rezai, S1
Vielman, M1
Henderson, CE1
Feghali, MN1
Scifres, CM1
Funk, MJ1
Bircsak, KM1
Gupta, V1
Yuen, PY1
Gorczyca, L1
Weinberger, BI1
Vetrano, AM1
Malek, R1
Vääräsmäki, M1
Bajaj, S1
Koren, R1
Ashwal, E1
Hod, M4
Bergel, R1
Zafran, N1
Salim, R1
Hissin, N1
Hasanein, J1
Gam Ze Letova, Y1
Suleiman, A1
Brown, J1
Martis, R1
Hughes, B1
Rowan, J1
Crowther, CA1
Pollex, E1
Lubetsky, A3
Gedeon, C2
Anger, G1
Miller, MP1
Nicholson, W2
Bolen, S2
Witkop, CT2
Neale, D1
Wilson, L1
Bass, E1
Stefulj, J1
Panzenboeck, U1
Becker, T1
Hirschmugl, B1
Schweinzer, C1
Lang, I1
Marsche, G1
Sadjak, A1
Lang, U1
Desoye, G1
Wadsack, C1
Naraharisetti, SB3
Krudys, KM1
Umans, JG1
Miodovnik, M1
Mattison, DR3
Kelly, EJ1
Blough, D1
Cobelli, C1
Snodgrass, WR1
Carr, DB1
Vicini, P1
Zhou, Y1
Fathali, N1
Lekic, T1
Zhang, JH1
Glatstein, MM1
Djokanovic, N1
Garcia-Bournissen, F1
Finkelstein, Y1
Lain, KY1
Garabedian, MJ1
Daftary, A1
Jeyabalan, A1
Cheung, NW1
Buttigieg, J1
Brown, S1
Holloway, AC1
Nurse, CA1
Mazaki-Tovi, S1
Romero, R1
Vaisbuch, E1
Mittal, P1
Chaiworapongsa, T1
Kim, SK1
Pacora, P1
Yeo, L1
Gotsch, F1
Dong, Z1
Yoon, BH1
Hassan, SS1
Kusanovic, JP1
Paglia, MJ1
Zharikova, OL3
Hill, RA2
Cygalova, LH1
Hofman, J1
Ceckova, M1
Staud, F1
Melamed, N2
Yogev, Y4
Moore, LE1
Clokey, D1
Rappaport, VJ1
Curet, LB1
Ross, MG1
Kjos, SL1
Pollex, EK1
Carles, G1
Germain, L1
Alassas, N1
El Guindi, W1
Dallah, F1
Daigre, JL1
Rosenn, BM1
Anger, GJ1
Piquette-Miller, M2
Hemauer, SJ1
Patrikeeva, SL1
Silva, JC4
Pacheco, C1
Bizato, J1
de Souza, BV1
Ribeiro, TE1
Bertini, AM4
Zhou, L2
Zhang, Y1
Ross, GR1
Yallampalli, U1
Gangula, PR1
Reed, L1
Sathishkumar, K1
Chauhan, M1
Milan, R1
Flores-Herrera, O1
Espinosa-Garcia, MT1
Olvera-Sanchez, S1
Martinez, F1
Dhulkotia, JS1
Ola, B1
Fraser, R1
Farrell, T1
Black, MH1
Xiang, AH1
Lawrence, JM1
Chen, R2
Nassie, D1
Pardo, J1
Maymone, AC1
Baillargeon, JP1
Ménard, J1
Ardilouze, JL1
Baptiste-Roberts, K2
Brustman, L1
Fuchs, A1
Ramos, GA4
Hanley, AA1
Aguayo, J1
Warshak, CR1
Kim, JH1
Moore, TR3
Refuerzo, JS1
Cheng, YW2
Chung, JH1
Block-Kurbisch, I1
Inturrisi, M1
Spellacy, WN1
Ballas, J1
Ducza, E1
Pridjian, G1
Fachin, DR1
Coral, ML1
Zhelyazkova-Savova, M1
Joy, S1
Roman, A1
Istwan, N1
Rhea, D1
Desch, C1
Stanziano, G1
Saltzman, D1
Hawkins, JZ1
Wing, D1
Robinson, H1
Wray, S2
Zertal-Zidani, S1
Busiah, K1
Edelman, A1
Polak, M1
Scharfmann, R1
Omori, Y1
Glueck, CJ1
Goldenberg, N1
Streicher, P1
Wang, P1
Tamás, G1
Kerényi, Z1
Guiet-Bara, A1
Bara, M1
Lehtihet, M1
Welsh, N1
Berggren, PO1
Cook, GA1
Sjoholm, A1
Cetin, A1
Kaya, T2
Demirkoprulu, N1
Karadas, B2
Duran, B1
Cetin, M1
Reece, EA1
Conway, DL2
Gonzales, O2
Skiver, D1
Chmait, R1
Dinise, T1
Moore, T1
Kremer, CJ1
Duff, P1
Ben-Haroush, A1
Waleh, N1
Kajino, H1
Marrache, AM1
Ginzinger, D1
Roman, C2
Seidner, SR1
Moss, TJ1
Fouron, JC1
Vazquez-Tello, A1
Chemtob, S1
Clyman, RI1
Xenakis, EM2
Bisseling, TM1
Versteegen, MG1
van der Wal, S1
Copius Peereboom-Stegeman, JJ1
Borggreven, JM1
Steegers, EA1
van der Laak, JA1
Russel, FG1
Smits, P1
Durnwald, C1
Jacobson, GF2
Ching, JY2
Kirby, RS2
Field, DR2
Mandi, G1
Sarkar, SN1
Mishra, SK1
Raviprakash, V1
Taborda, W2
Becker, F2
Lemos Bebber, FR1
Zucco Viesi, JM1
Aquim, G1
Engel Ribeiro, T1
Kraemer, J1
Klein, J1
Rand, L2
Kahn, BF1
Lynch, AM1
Scollan-Koliopoulos, M1
Guadagno, S1
Walker, EA1
Nekhayeva, I1
Yoo, KY1
Lee, JC1
Yoon, MH1
Shin, MH1
Kim, SJ1
Kim, YH1
Song, TB1
Lima, R1
Tardim, JC1
Barros, ME1
Boim, MA1
de Buys Roessingh, AS1
de Lagausie, P1
Barbet, JP1
Mercier, JC1
Aigrain, Y1
Dinh-Xuan, AT1
Rochon, M1
Roth, L1
Gaddipati, S1
Anjalakshi, C1
Balaji, V1
Balaji, MS1
Seshiah, V1
MacLeod, S1
Davis, D1
Khurana, A1
Vinayek, N1
Ravindran, S2
Bebber, FR1
Aquim, GM1
Viesi, JM1
Kirby, BJ1
Kapur, B1
Wang, H1
Clarke, P1
Parry, EC1
Coleman, MA1
Schaefer-Graf, UM1
Kleinwechter, H1
Kelly, L1
Patrikeeva, S1
Hemauer, S1
Fokina, V1
Mattison, D1
Jain, S1
Nanovskya, TN1
Moretti, ME1
Rezvani, M1
Nicholson, WK1
Wilson, LM1
Bennett, WL1
Barone, BB1
Golden, SH1
Gary, TL1
Neale, DM1
Bass, EB1
Petrovic, V1
Wang, JH1
Dermietzel, R1
Leibstein, A1
Frixen, U1
Janssen-Timmen, U1
Traub, O1
Willecke, K1
Coetzee, EJ2
Jackson, WP2
Beinze, E1
Nguyen Thi, C1
Vetter, U1
Fussgänger, RD1
Sivan, E1
Feldman, B1
Dolitzki, M1
Nevo, N1
Dekel, N1
Karasik, A1
Ravina, A1
Wong, J1
Fineman, JR2
Heymann, MA3
Elliott, BD2
Schenker, S2
Johnson, R1
Prihoda, T1
Heaton, RC1
Eisner, DA1
Nelson, SH1
Suresh, MS1
Dehring, DJ1
Johnson, RL1
Xia, Y1
Eisenman, D1
Haddad, GG1
Cheuk, JM1
Hollingsworth, M2
Hughes, SJ1
Piper, IT1
Maresh, MJ1
Cornfield, DN2
Reeve, HL1
Tolarova, S2
Weir, EK2
Archer, S1
Tristani-Firouzi, M1
Martin, EB1
Archer, SL1
Baker, JE1
Contney, SJ1
Gross, GJ1
Bosnjak, ZJ1
Khan, RN1
Morrison, JJ2
Smith, SK1
Ashford, ML1
Keyes, L1
Rodman, DM1
Curran-Everett, D1
Morris, K1
Moore, LG1
Parkington, HC1
Tonta, MA1
Davies, NK1
Brennecke, SP1
Coleman, HA1
Takahashi, Y1
de Vroomen, M1
Gournay, V1
Rudolph, AM1
Pacher, P1
Ungvári, Z1
Nánási, PP1
Mucha, I1
Kecskeméti, V1
Losonczy, G1
Okawa, T1
Vedernikov, YP1
Saade, GR1
Longo, M1
Olson, GL1
Chwalisz, K1
Garfield, RE1
Lader, AS1
Wang, Y1
Jackson, GR1
Borkan, SC1
Cantiello, HF1
Cadorette, C1
Sicotte, B1
Brochu, M1
St-Louis, J1
Lim, JM1
Tayob, Y1
O'Brien, PM1
Shaw, RW1
Tiritilli, A1
Berkus, MD1
Greene, MF1
Thompson, LP1
Aguan, K1
Pinkas, G1
Weiner, CP1
Letonturier, P1
Sriram, U1
Gosche, JR1
Dornan, T1
Hollis, S1
Dornhorst, A1
Kafali, H1
Gürsoy, S1
Bagcivan, I1
Sarioglu, Y1
Collett, A1
Ramminger, SJ1
Olver, RE1
Wilson, SM1
Houlihan, DD1
Dennedy, MC1
Heinze, E1
Beischer, W1
Osorio, J1
Pfeiffer, EF1
Watson, WA1
Petrie, JC1
Galloway, DB1
Bullock, I1
Gilbert, JC1
Nishi, R1
Kaito, H1
Triggle, CR1
Li, YQ1
Wyse, DG1
Chang, JK1
Moore, P1
Soifer, SJ1
Johnson, RF1
Piper, I1
Minshall, E1
Downing, SJ1
Sadraei, H1
Villar, A1
Ivorra, MD1
D'Ocon, MP1
Anselmi, E1
Tattersall, RB1
Heisig, N1
Schröder, G1

Clinical Trials (14)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparative Studies of Metformin and Insulin on Stereological Studies and Immunohistochemistry of Placenta[NCT04907708]156 participants (Actual)Interventional2018-01-01Completed
A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS[NCT02080377]Phase 323 participants (Actual)Interventional2014-07-31Completed
Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational Diabetes[NCT01731431]Phase 3914 participants (Actual)Interventional2012-05-18Completed
[NCT01947699]Phase 40 participants (Actual)Interventional2013-09-30Withdrawn (stopped due to PI decided to withdrawal study before recruitment started)
Glyburide and Metformin for the Treatment of Gestational Diabetes Mellitus. A Systematic Review and Meta-analysis of Randomized Controlled Trials Comparing These Drugs Either vs Insulin or vs Each Other.[NCT01998113]2,509 participants (Actual)Observational2013-03-31Completed
Effect of Metformin on Healthy Live Birth After In-vitro Fertilization in Women With Prediabetes Mellitus: a Multicenter Double-blind Placebo Controlled Randomized Trial[NCT06064669]988 participants (Anticipated)Interventional2023-10-01Not yet recruiting
A Randomized Controlled Clinical Trial of Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo[NCT00744965]Phase 4395 participants (Actual)Interventional2008-09-16Completed
[NCT01563120]Phase 4108 participants (Actual)Interventional2012-01-31Completed
Study of Awareness of Gestational Diabetes Problem Among Sohag Governorate Women[NCT05148897]500 participants (Anticipated)Observational [Patient Registry]2021-10-01Recruiting
A Randomized Prospective Trial of Metformin Compared to Glyburide in Gestational Diabetes[NCT00965991]149 participants (Actual)Interventional2003-07-31Completed
Glyburide vs Glucovance in the Treatment of Gestational Diabetes[NCT02726490]Early Phase 17 participants (Actual)Interventional2016-07-31Terminated (stopped due to Lack of Recruitment)
Effects of Choline Supplementation on Fetal Growth in Gestational Diabetes Mellitus[NCT04302168]60 participants (Anticipated)Interventional2020-04-01Recruiting
Pulsatile GnRH in Anovulatory Infertility[NCT00383656]Phase 2270 participants (Anticipated)Interventional1989-01-31Recruiting
Non-inferiority Between Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus: a Randomized Multicenter and Prospective Trial. ACARB-GDM Study.[NCT03380546]Phase 3341 participants (Actual)Interventional2018-07-04Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

3rd or 4th Degree Perineal Laceration

(NCT00744965)
Timeframe: at delivery

InterventionParticipants (Count of Participants)
Placebo5
Glyburide1

Chorioamnionitis

Maternal fever >=38.0°C (NCT00744965)
Timeframe: intrapartum

InterventionParticipants (Count of Participants)
Placebo12
Glyburide15

Diagnosis of Pregnancy-induced Hypertension

(NCT00744965)
Timeframe: until hospital discharge

InterventionParticipants (Count of Participants)
Placebo12
Glyburide15

Macrosomia

birth weight 4,000 g or greater (NCT00744965)
Timeframe: After delivery

InterventionParticipants (Count of Participants)
Placebo18
Glyburide13

Mean Fetal Weight at Birth

(NCT00744965)
Timeframe: Immediately after delivery of fetus

Interventiongrams (Mean)
Placebo3355
Glyburide3322

Need for Insulin Therapy

(NCT00744965)
Timeframe: throughout pregnancy and delivery

InterventionParticipants (Count of Participants)
Placebo4
Glyburide4

Need for Insulin Treatment

(NCT00744965)
Timeframe: after delivery

InterventionParticipants (Count of Participants)
Placebo4
Glyburide4

Neonatal Intensive Care Unit Admissions

(NCT00744965)
Timeframe: Until hospital discharge

InterventionParticipants (Count of Participants)
Placebo11
Glyburide13

Number of Participants With Large for Gestational Age Infants

Birth weight exceeding the 90th percentile for the gestational age at delivery. (NCT00744965)
Timeframe: After delivery

InterventionParticipants (Count of Participants)
Placebo22
Glyburide20

Rate of Cesarean Delivery

(NCT00744965)
Timeframe: After delivery

InterventionParticipants (Count of Participants)
Placebo67
Glyburide70

Shoulder Dystocia

(NCT00744965)
Timeframe: at delivery

InterventionParticipants (Count of Participants)
Placebo1
Glyburide0

Number of Participants Assessed for Glucose Control

The importance of exercise in the management of blood glucose was emphasized, and 30 minutes of walking per day was recommended. Patients received instruction from a nurse educator or a certified diabetes educator regarding diet and the use of the glucometer. Number of participants with a glucose level <100 mg/dL. (NCT00965991)
Timeframe: fasting and 2 hour postprandial blood glucose

InterventionParticipants (Count of Participants)
Metformin50
Glyburide50

Reviews

67 reviews available for glyburide and Pregnancy

ArticleYear
Glycemic control and neonatal outcomes in women with gestational diabetes mellitus treated using glyburide, metformin, or insulin: a pairwise and network meta-analysis.
    BMC endocrine disorders, 2021, Oct-12, Volume: 21, Issue:1

    Topics: Adult; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Glycemic Control; Humans; Hypoglycem

2021
Comparison of the effectiveness and safety of insulin and oral hypoglycemic drugs in the treatment of gestational diabetes mellitus: a meta-analysis of 26 randomized controlled trials.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2022, Volume: 38, Issue:4

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Infant, Newborn; Insulin; Met

2022
Metformin versus glyburide in treatment and control of gestational diabetes mellitus: a systematic review with meta-analysis.
    Einstein (Sao Paulo, Brazil), 2022, Volume: 20

    Topics: Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Infant, Newbor

2022
Incretins as a Potential Treatment Option for Gestational Diabetes Mellitus.
    International journal of molecular sciences, 2022, Sep-03, Volume: 23, Issue:17

    Topics: Blood Glucose; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dipeptidyl-Peptidase IV Inhibitors;

2022
Medications for Managing Preexisting and Gestational Diabetes in Pregnancy.
    Obstetrics and gynecology clinics of North America, 2023, Volume: 50, Issue:1

    Topics: Child; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Metformin; Pr

2023
Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis.
    Journal of diabetes research, 2019, Volume: 2019

    Topics: Adult; Biomarkers; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Age

2019
The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy.
    Current diabetes reports, 2019, 12-06, Volume: 19, Issue:12

    Topics: Acarbose; Diabetes, Gestational; Female; Glyburide; Healthy Lifestyle; Humans; Hypoglycemic Agents;

2019
Can glyburide be advocated over subcutaneous insulin for perinatal outcomes of women with gestational diabetes? A systematic review and meta-analysis.
    Archives of gynecology and obstetrics, 2020, Volume: 301, Issue:1

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Infusions, Subcutaneous; Insu

2020
Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: A systematic review and meta-analysis.
    PLoS medicine, 2020, Volume: 17, Issue:5

    Topics: Anthropometry; Birth Weight; Blood Glucose; Diabetes, Gestational; Female; Fetal Macrosomia; Glyburi

2020
Gestational Diabetes Mellitus Pharmacological Prevention and Treatment.
    Current pharmaceutical design, 2021, Volume: 27, Issue:36

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Metformin; Pregnancy

2021
Metformin is comparable to insulin for pharmacotherapy in gestational diabetes mellitus: A network meta-analysis evaluating 6046 women.
    Pharmacological research, 2021, Volume: 167

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Metformin; Pregnancy

2021
Comparison of Insulin, Metformin, and Glyburide on Perinatal Complications of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis.
    Gynecologic and obstetric investigation, 2021, Volume: 86, Issue:3

    Topics: Cesarean Section; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Infant, New

2021
Effectiveness of antidiabetic agents for treatment of gestational diabetes: A methodological quality assessment of meta-analyses and network meta-analysis.
    Journal of diabetes investigation, 2021, Volume: 12, Issue:12

    Topics: Adult; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Infant,

2021
Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options.
    Current opinion in pharmacology, 2021, Volume: 60

    Topics: Diabetes, Gestational; Female; Fetal Development; Glyburide; Humans; Hypoglycemic Agents; Infant, Ne

2021
Treatments for gestational diabetes: a systematic review and meta-analysis.
    BMJ open, 2017, 06-24, Volume: 7, Issue:6

    Topics: Bayes Theorem; Cesarean Section; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agen

2017
Comparison of glyburide and insulin in the management of gestational diabetes: A meta-analysis.
    PloS one, 2017, Volume: 12, Issue:8

    Topics: Adult; Birth Weight; Diabetes, Gestational; Disease Management; Female; Glyburide; Humans; Hypoglyce

2017
The care of pregestational and gestational diabetes and drug metabolism considerations.
    Expert opinion on drug metabolism & toxicology, 2017, Volume: 13, Issue:10

    Topics: Animals; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic

2017
Pharmacological Management of Gestational Diabetes Mellitus.
    Drugs, 2017, Volume: 77, Issue:16

    Topics: Acarbose; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemi

2017
Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis.
    Medicine, 2017, Volume: 96, Issue:38

    Topics: Administration, Oral; Adult; Blood Glucose; Comparative Effectiveness Research; Diabetes, Gestationa

2017
Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta-analysis of randomized trials.
    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2018, Volume: 52, Issue:6

    Topics: Bayes Theorem; Diabetes, Gestational; Female; Glyburide; Humans; Hypertension, Pregnancy-Induced; In

2018
Oral Agents for the Treatment of Gestational Diabetes.
    Current diabetes reports, 2018, 09-28, Volume: 18, Issue:11

    Topics: Administration, Oral; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin

2018
Pharmacologic Treatment of Diabetes in Pregnancy.
    Obstetrical & gynecological survey, 2019, Volume: 74, Issue:5

    Topics: Diabetes, Gestational; Exercise; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Metformin;

2019
Oral agents for the management of gestational diabetes.
    Clinical obstetrics and gynecology, 2013, Volume: 56, Issue:4

    Topics: Administration, Oral; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Metform

2013
Is glyburide safe in pregnancy?
    Current pharmaceutical biotechnology, 2014, Volume: 15, Issue:1

    Topics: Animals; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Maternal-Fetal Excha

2014
The use of glyburide in the management of gestational diabetes mellitus: a meta-analysis.
    Advances in medical sciences, 2014, Volume: 59, Issue:1

    Topics: Birth Weight; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents;

2014
Unresolved controversies in gestational diabetes: implications on maternal and infant health.
    Current opinion in endocrinology, diabetes, and obesity, 2014, Volume: 21, Issue:4

    Topics: Caloric Restriction; Diabetes, Gestational; Diet, Carbohydrate-Restricted; Diet, Diabetic; Female; F

2014
Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: a meta-analysis.
    PloS one, 2014, Volume: 9, Issue:10

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Metformin; Pregnancy

2014
Gestational diabetes mellitus management with oral hypoglycemic agents.
    Seminars in perinatology, 2014, Volume: 38, Issue:8

    Topics: Administration, Oral; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin

2014
Screening and management of gestational diabetes.
    Best practice & research. Clinical obstetrics & gynaecology, 2015, Volume: 29, Issue:3

    Topics: Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diet

2015
Safety considerations with pharmacological treatment of gestational diabetes mellitus.
    Drug safety, 2015, Volume: 38, Issue:1

    Topics: Animals; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic

2015
Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis.
    BMJ (Clinical research ed.), 2015, Jan-21, Volume: 350

    Topics: Adult; Birth Weight; Diabetes, Gestational; Female; Fetal Macrosomia; Glyburide; Humans; Hypoglycemi

2015
Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis.
    BMJ (Clinical research ed.), 2015, Jan-21, Volume: 350

    Topics: Adult; Birth Weight; Diabetes, Gestational; Female; Fetal Macrosomia; Glyburide; Humans; Hypoglycemi

2015
Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis.
    BMJ (Clinical research ed.), 2015, Jan-21, Volume: 350

    Topics: Adult; Birth Weight; Diabetes, Gestational; Female; Fetal Macrosomia; Glyburide; Humans; Hypoglycemi

2015
Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis.
    BMJ (Clinical research ed.), 2015, Jan-21, Volume: 350

    Topics: Adult; Birth Weight; Diabetes, Gestational; Female; Fetal Macrosomia; Glyburide; Humans; Hypoglycemi

2015
Using oral agents to manage gestational diabetes: what have we learned?
    Current diabetes reports, 2015, Volume: 15, Issue:2

    Topics: Acarbose; Administration, Oral; Birth Weight; Diabetes, Gestational; Female; Glyburide; Humans; Hypo

2015
Comparative efficacy and safety of OADs in management of GDM: network meta-analysis of randomized controlled trials.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:5

    Topics: Administration, Oral; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic

2015
Comparison of glyburide with metformin in treating gestational diabetes mellitus: a systematic review and meta-analysis.
    Clinical drug investigation, 2015, Volume: 35, Issue:6

    Topics: Adult; Birth Weight; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Infant,

2015
Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus.
    Expert opinion on drug metabolism & toxicology, 2016, Volume: 12, Issue:6

    Topics: Animals; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Infan

2016
Is it worth treating gestational diabetes: if so, when and how?
    Diabetologia, 2016, Volume: 59, Issue:7

    Topics: Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Metformin; Pregnancy; Pregnancy Com

2016
Pharmacological Management of Gestational Diabetes Mellitus.
    Current diabetes reports, 2016, Volume: 16, Issue:11

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Metformin; Pregnancy

2016
Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes.
    The Cochrane database of systematic reviews, 2017, 01-25, Volume: 1

    Topics: Acarbose; Administration, Oral; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemia; Hypo

2017
Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review.
    Obstetrics and gynecology, 2009, Volume: 113, Issue:1

    Topics: Acarbose; Administration, Oral; Birth Weight; Diabetes, Gestational; Female; Glyburide; Humans; Hypo

2009
Use of hypoglycemic drugs during lactation.
    Canadian family physician Medecin de famille canadien, 2009, Volume: 55, Issue:4

    Topics: Administration, Oral; Breast Feeding; Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adver

2009
The management of gestational diabetes.
    Vascular health and risk management, 2009, Volume: 5, Issue:1

    Topics: Administration, Oral; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes, Gestational; Drug Admi

2009
The use of oral antidiabetic medications in gestational diabetes mellitus.
    Current diabetes reports, 2009, Volume: 9, Issue:4

    Topics: Administration, Oral; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Metform

2009
Can pregnant diabetics be treated with glyburide?
    Women's health (London, England), 2009, Volume: 5, Issue:6

    Topics: Diabetes, Gestational; Drug Therapy, Combination; Female; Glyburide; Humans; Hypoglycemic Agents; In

2009
Oral hypoglycemic therapy: understanding the mechanisms of transplacental transfer.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2010, Volume: 23, Issue:3

    Topics: Administration, Oral; Biological Transport; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female

2010
[Treatment of gestational diabetes with oral hypoglycemic agents].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 2010, Volume: 39, Issue:2

    Topics: Diabetes, Gestational; Female; Fetal Macrosomia; Glucose Tolerance Test; Glyburide; Humans; Hypoglyc

2010
The glyburide report card.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2010, Volume: 23, Issue:3

    Topics: Blood Glucose; Cohort Studies; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents

2010
Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis.
    American journal of obstetrics and gynecology, 2010, Volume: 203, Issue:5

    Topics: Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Metfo

2010
Oral hypoglycemic agents for gestational diabetes mellitus?
    Expert opinion on drug safety, 2011, Volume: 10, Issue:2

    Topics: Administration, Oral; Animals; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents

2011
Oral hypoglycaemic agents during pregnancy: The evidence for effectiveness and safety.
    Best practice & research. Clinical obstetrics & gynaecology, 2011, Volume: 25, Issue:1

    Topics: Acarbose; Administration, Oral; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agent

2011
Management of diabetes in pregnancy.
    Current diabetes reports, 2012, Volume: 12, Issue:1

    Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Glyburide; Huma

2012
What is new in diabetes?: best articles from the past year.
    Obstetrics and gynecology, 2012, Volume: 119, Issue:2 Pt 1

    Topics: Body Weight; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Glyburide;

2012
[Drug therapy for diabetes mellitus during pregnancy and breastfeeding in the beginning of 21 century: status quo and new challenges].
    Akusherstvo i ginekologiia, 2012, Volume: 51, Issue:1

    Topics: Breast Feeding; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulins; Met

2012
Abnormal glucose metabolism: diagnosis and management in the ambulatory setting.
    Clinical obstetrics and gynecology, 2012, Volume: 55, Issue:3

    Topics: Ambulatory Care; Blood Glucose Self-Monitoring; Diabetes, Gestational; Diet Therapy; Exercise Therap

2012
[Medical management of pregnant women with diabetes].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 9

    Topics: Blood Glucose; Body Weight; Congenital Abnormalities; Diabetic Nephropathies; Diabetic Retinopathy;

2002
The contentious nature of gestational diabetes: diet, insulin, glyburide and metformin.
    Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:11

    Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Glyburide; Human

2002
Current controversies in the mechanisms and treatment of gestational diabetes.
    Current diabetes reports, 2002, Volume: 2, Issue:4

    Topics: Autoimmune Diseases; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic A

2002
Management of gestational diabetes: pharmacologic treatment options and glycemic control.
    Endocrinology and metabolism clinics of North America, 2006, Volume: 35, Issue:1

    Topics: Administration, Oral; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic

2006
Gestational diabetes management: guidelines to a healthy pregnancy.
    The Nurse practitioner, 2006, Volume: 31, Issue:6

    Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Diet, Diabetic; Estrogens; Exercise; Female; Fetal

2006
Pharmacological management of gestational diabetes: an overview.
    Diabetes care, 2007, Volume: 30 Suppl 2

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Metformin; Pregnancy

2007
Glyburide for the treatment of gestational diabetes. A critical appraisal.
    Diabetes care, 2007, Volume: 30 Suppl 2

    Topics: Administration, Oral; Case-Control Studies; Diabetes, Gestational; Female; Glyburide; Humans; Hypogl

2007
Diagnosis and new approaches in the therapy of gestational diabetes mellitus.
    Current diabetes reviews, 2006, Volume: 2, Issue:3

    Topics: Blood Glucose; Diabetes, Gestational; Female; Fetal Development; Fetus; Glyburide; Humans; Hypoglyce

2006
Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes.
    The Annals of pharmacotherapy, 2008, Volume: 42, Issue:4

    Topics: Congenital Abnormalities; Diabetes, Gestational; Female; Fetal Blood; Fetal Macrosomia; Glyburide; H

2008
Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes.
    Evidence report/technology assessment, 2008, Issue:162

    Topics: Birth Weight; Blood Glucose; Cesarean Section; Diabetes, Gestational; Female; Fetal Macrosomia; Glyb

2008
Post-prandial hyperglycemia and its implications in pregnancy and lipid abnormalities.
    The Journal of the Association of Physicians of India, 2001, Jan-25, Volume: 49 Spec No

    Topics: Female; Glyburide; Humans; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Postprandial Period;

2001
Critical appraisal of published research evidence: treatment of gestational diabetes.
    Diabetic medicine : a journal of the British Diabetic Association, 2001, Volume: Suppl 3

    Topics: Attitude of Health Personnel; Clinical Trials as Topic; Diabetes, Gestational; Evidence-Based Medici

2001
Oral hypoglycemic agents and the pregnant diabetic: "from bench to bedside".
    Seminars in perinatology, 2002, Volume: 26, Issue:3

    Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Evidence-Based Medicine; Female; Glyburide; Humans

2002
Glibenclamide: a review.
    Drugs, 1971, Volume: 1, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Animals; Biguanides; Blood Glucose; Carbon Isotopes;

1971

Trials

22 trials available for glyburide and Pregnancy

ArticleYear
SUGAR-DIP trial: oral medication strategy versus insulin for diabetes in pregnancy, study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial.
    BMJ open, 2019, 08-18, Volume: 9, Issue:8

    Topics: Administration, Oral; Blood Glucose; Cost-Benefit Analysis; Diabetes, Gestational; Drug Therapy, Com

2019
Pharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin Combination Therapy in the Treatment of Gestational Diabetes Mellitus.
    Clinical pharmacology and therapeutics, 2020, Volume: 107, Issue:6

    Topics: Adolescent; Adult; Blood Glucose; Diabetes, Gestational; Drug Therapy, Combination; Female; Glyburid

2020
Transplacental transfer of glyburide in women with gestational diabetes and neonatal hypoglycemia risk.
    PloS one, 2020, Volume: 15, Issue:5

    Topics: Administration, Oral; Adult; Diabetes, Gestational; Dose-Response Relationship, Drug; Female; Fetal

2020
Glyburide therapy for gestational diabetes: Glycaemic control, maternal hypoglycaemia, and treatment failure.
    Diabetes & metabolism, 2021, Volume: 47, Issue:4

    Topics: Diabetes, Gestational; Female; Glyburide; Glycemic Control; Humans; Hypoglycemia; Hypoglycemic Agent

2021
Hypoglycemia and Glycemic Control With Glyburide in Women With Gestational Diabetes and Genetic Variants of Cytochrome P450 2C9 and/or OATP1B3.
    Clinical pharmacology and therapeutics, 2021, Volume: 110, Issue:1

    Topics: Adult; Cytochrome P-450 CYP2C9; Diabetes, Gestational; Dose-Response Relationship, Drug; Female; Gen

2021
Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial.
    BMC pregnancy and childbirth, 2017, Sep-22, Volume: 17, Issue:1

    Topics: Adult; Blood Glucose; Diabetes, Gestational; Drug Therapy, Combination; Feasibility Studies; Female;

2017
Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial.
    JAMA, 2018, 05-01, Volume: 319, Issue:17

    Topics: Administration, Oral; Adult; Blood Glucose; Diabetes, Gestational; Female; Fetal Macrosomia; Glyburi

2018
Glyburide as treatment option for gestational diabetes mellitus.
    The journal of obstetrics and gynaecology research, 2013, Volume: 39, Issue:6

    Topics: Adult; Diabetes, Gestational; Female; Fetal Diseases; Glyburide; Humans; Hypoglycemic Agents; Insuli

2013
Comparison of neonatal outcomes in women with gestational diabetes with moderate hyperglycaemia on metformin or glibenclamide--a randomised controlled trial.
    The Australian & New Zealand journal of obstetrics & gynaecology, 2015, Volume: 55, Issue:1

    Topics: Adult; Birth Injuries; Birth Weight; Diabetes, Gestational; Female; Fetal Macrosomia; Glyburide; Hum

2015
Comparison of glyburide and insulin in women with gestational diabetes mellitus and associated perinatal outcome: a randomized clinical trial.
    Acta medica Iranica, 2015, Volume: 53, Issue:2

    Topics: Adolescent; Adult; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemia; Hy

2015
Glyburide in Women With Mild Gestational Diabetes: A Randomized Controlled Trial.
    Obstetrics and gynecology, 2015, Volume: 126, Issue:2

    Topics: Adult; Blood Glucose; Diabetes, Gestational; Diet, Diabetic; Drug Monitoring; Female; Glucose Tolera

2015
Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study.
    Diabetes care, 2017, Volume: 40, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Blood Glucose; Diabetes, Gestational; Drug Therapy, Combina

2017
Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice.
    Clinical pharmacology and therapeutics, 2009, Volume: 85, Issue:6

    Topics: Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Blood Glucose; Cytochrome P-450 CYP2C9; Diab

2009
Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared with insulin.
    American journal of obstetrics and gynecology, 2009, Volume: 200, Issue:5

    Topics: Adipose Tissue; Adult; Birth Weight; Body Composition; Body Size; Diabetes, Gestational; Female; Fet

2009
Metformin compared with glyburide in gestational diabetes: a randomized controlled trial.
    Obstetrics and gynecology, 2010, Volume: 115, Issue:1

    Topics: Adult; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Metform

2010
Metformin compared with glyburide in gestational diabetes: a randomized controlled trial.
    Obstetrics and gynecology, 2010, Volume: 115, Issue:1

    Topics: Adult; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Metform

2010
Metformin compared with glyburide in gestational diabetes: a randomized controlled trial.
    Obstetrics and gynecology, 2010, Volume: 115, Issue:1

    Topics: Adult; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Metform

2010
Metformin compared with glyburide in gestational diabetes: a randomized controlled trial.
    Obstetrics and gynecology, 2010, Volume: 115, Issue:1

    Topics: Adult; Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Metform

2010
Metformin compared with glyburide for the management of gestational diabetes.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2010, Volume: 111, Issue:1

    Topics: Birth Weight; Blood Glucose; Diabetes, Gestational; Fasting; Female; Glyburide; Glycated Hemoglobin;

2010
Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus.
    Journal of perinatal medicine, 2012, Jan-10, Volume: 40, Issue:3

    Topics: Adult; Birth Weight; Blood Glucose; Diabetes, Gestational; Female; Glucose Tolerance Test; Glyburide

2012
Perinatal outcomes and the use of oral hypoglycemic agents.
    Journal of perinatal medicine, 2005, Volume: 33, Issue:6

    Topics: Acarbose; Administration, Oral; Adult; Birth Weight; Blood Glucose; Diabetes, Gestational; Female; F

2005
A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women.
    Diabetes research and clinical practice, 2007, Volume: 76, Issue:3

    Topics: Adult; Diabetes, Gestational; Female; Glyburide; Humans; India; Insulin; Pregnancy

2007
[Glibenclamide in the treatment for gestational diabetes mellitus in a compared study to insulin].
    Arquivos brasileiros de endocrinologia e metabologia, 2007, Volume: 51, Issue:4

    Topics: Adult; Birth Weight; Blood Glucose; Chi-Square Distribution; Diabetes, Gestational; Drug Therapy, Co

2007
A comparison of glyburide and insulin in women with gestational diabetes mellitus.
    The New England journal of medicine, 2000, Oct-19, Volume: 343, Issue:16

    Topics: Adolescent; Adult; Blood Glucose; Congenital Abnormalities; Diabetes, Gestational; Female; Fetal Blo

2000
A comparison of glyburide and insulin in women with gestational diabetes mellitus.
    The New England journal of medicine, 2000, Oct-19, Volume: 343, Issue:16

    Topics: Adolescent; Adult; Blood Glucose; Congenital Abnormalities; Diabetes, Gestational; Female; Fetal Blo

2000
A comparison of glyburide and insulin in women with gestational diabetes mellitus.
    The New England journal of medicine, 2000, Oct-19, Volume: 343, Issue:16

    Topics: Adolescent; Adult; Blood Glucose; Congenital Abnormalities; Diabetes, Gestational; Female; Fetal Blo

2000
A comparison of glyburide and insulin in women with gestational diabetes mellitus.
    The New England journal of medicine, 2000, Oct-19, Volume: 343, Issue:16

    Topics: Adolescent; Adult; Blood Glucose; Congenital Abnormalities; Diabetes, Gestational; Female; Fetal Blo

2000
[Gestational diabetes: an alternative to insulin therapy?].
    Presse medicale (Paris, France : 1983), 2001, Feb-03, Volume: 30, Issue:4

    Topics: Adult; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Pregnancy

2001

Other Studies

163 other studies available for glyburide and Pregnancy

ArticleYear
Changing patterns in medication prescription for gestational diabetes during a time of guideline change in the USA: a cross-sectional study.
    BJOG : an international journal of obstetrics and gynaecology, 2022, Volume: 129, Issue:3

    Topics: Adolescent; Adult; Cross-Sectional Studies; Diabetes, Gestational; Drug Prescriptions; Female; Glybu

2022
Modulation of Placental Breast Cancer Resistance Protein by HDAC1 in Mice: Implications for Optimization of Pharmacotherapy During Pregnancy.
    Reproductive sciences (Thousand Oaks, Calif.), 2021, Volume: 28, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; Female; Gene Silencing; Glyburide;

2021
Correlates of Insulin Selection as a First-Line Pharmacological Treatment for Gestational Diabetes.
    American journal of perinatology, 2022, Volume: 39, Issue:1

    Topics: Administration, Oral; Adult; Analysis of Variance; Blood Glucose; Diabetes, Gestational; Female; Gly

2022
Kv7.4 channels regulate potassium permeability in neuronal mitochondria.
    Biochemical pharmacology, 2022, Volume: 197

    Topics: Animals; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Femal

2022
Antenatal maternal hypoglycemia in women with gestational diabetes mellitus and neonatal outcomes.
    Journal of perinatology : official journal of the California Perinatal Association, 2022, Volume: 42, Issue:8

    Topics: Diabetes, Gestational; Female; Fetal Macrosomia; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agent

2022
Comparative efficacy and safety of glyburide, metformin, and insulin in treatment of gestational diabetes mellitus: A protocol for systematic review and meta-analysis.
    Medicine, 2022, Mar-18, Volume: 101, Issue:11

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Meta-Analysis as Top

2022
Association of Glyburide and Subcutaneous Insulin With Perinatal Complications Among Women With Gestational Diabetes.
    JAMA network open, 2022, 03-01, Volume: 5, Issue:3

    Topics: Adult; Cohort Studies; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Infant

2022
In vivo pharmacokinetic analyses of placental transfer of three drugs of different physicochemical properties in pregnant rats.
    Reproductive toxicology (Elmsford, N.Y.), 2022, Volume: 111

    Topics: Animals; Female; Fentanyl; Fetus; Glyburide; Maternal-Fetal Exchange; Placenta; Pregnancy; Rats; Rat

2022
Early Postnatal Use of Glibenclamide in Permanent Neonatal Diabetes Secondary to Antenatally Diagnosed KJCN11 Mutation.
    Hormone research in paediatrics, 2022, Volume: 95, Issue:5

    Topics: Blood Glucose; Diabetes Mellitus; Female; Glyburide; Humans; Hypoglycemic Agents; Infant; Infant, Ne

2022
Efficacy and safety of hypoglycemic agents on gestational diabetes mellitus in women: A Bayesian network analysis of randomized controlled trials.
    Frontiers in public health, 2022, Volume: 10

    Topics: Birth Weight; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; I

2022
EXPERIMENTAL GESTATIONAL DIABETES DISRUPTS THE FORMATION OF IMMUNE TOLERANCE IN OFFSPRING.
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2023, Volume: 76, Issue:1

    Topics: Animals; CTLA-4 Antigen; Diabetes Mellitus, Experimental; Diabetes, Gestational; DNA-Binding Protein

2023
Insulin Detemir Versus Glibenclamide in Gestational Diabetes Mellitus: A Retrospective Cohort Study.
    The Israel Medical Association journal : IMAJ, 2023, Volume: 25, Issue:6

    Topics: Birth Weight; Diabetes, Gestational; Female; Glucose; Glyburide; Humans; Infant; Infant, Newborn; In

2023
Use of Antidiabetic drugs during pregnancy among U.S. women with Livebirth deliveries in the Mini-Sentinel system.
    BMC pregnancy and childbirth, 2019, Nov-27, Volume: 19, Issue:1

    Topics: Administrative Claims, Healthcare; Adolescent; Adult; Child; Databases, Factual; Diabetes Mellitus;

2019
Comparative effects of glibenclamide, metformin and insulin on fetal pancreatic histology and maternal blood glucose in pregnant streptozotocin-induced diabetic rats.
    African health sciences, 2019, Volume: 19, Issue:3

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes, Gestational; Female;

2019
Glibenclamide transfer across the perfused human placenta is determined by albumin binding not transporter activity.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2020, Sep-01, Volume: 152

    Topics: Albumins; ATP Binding Cassette Transporter, Subfamily G, Member 2; Female; Glyburide; Humans; Neopla

2020
Diabetes treatment in two pregnant women with permanent neonatal diabetes mellitus due to a KCNJ11 mutation.
    Diabetic medicine : a journal of the British Diabetic Association, 2020, Volume: 37, Issue:11

    Topics: Adult; Diabetes Mellitus; Drug Therapy, Combination; Female; Fetal Macrosomia; Glyburide; Glycemic C

2020
Characterization of women with gestational diabetes who failed to achieve glycemic control by lifestyle modifications.
    Archives of gynecology and obstetrics, 2021, Volume: 303, Issue:3

    Topics: Adult; Blood Glucose; Body Mass Index; Diabetes, Gestational; Female; Glucose Tolerance Test; Glybur

2021
Treatment of Gestational Diabetes Mellitus and Offspring Early Childhood Growth.
    The Journal of clinical endocrinology and metabolism, 2021, 03-25, Volume: 106, Issue:4

    Topics: Adult; Birth Weight; Child Development; Child, Preschool; Cohort Studies; Diabetes, Gestational; Die

2021
Comment on Nachum et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Diabetes Care 2017;40:332-337.
    Diabetes care, 2017, Volume: 40, Issue:8

    Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; In

2017
Response to Comment on Nachum et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Diabetes Care 2017;40:332-337.
    Diabetes care, 2017, Volume: 40, Issue:8

    Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; In

2017
Glyburide treatment in gestational diabetes is associated with increased placental glucose transporter 1 expression and higher birth weight.
    Placenta, 2017, Volume: 57

    Topics: Birth Weight; Diabetes, Gestational; Fatty Acid Transport Proteins; Female; Glucose Transporter Type

2017
Decreased insulin secretion in pregnant rats fed a low protein diet.
    Biology of reproduction, 2017, Oct-01, Volume: 97, Issue:4

    Topics: Animals; Arginine; Blood Glucose; Diet, Protein-Restricted; Dietary Proteins; Female; Glucose; Gluco

2017
Glibenclamide inhibits NLRP3 inflammasome-mediated IL-1β secretion in human trophoblasts.
    Journal of pharmacological sciences, 2017, Volume: 135, Issue:2

    Topics: Amides; Bucladesine; Caspase 1; Cell Differentiation; Cells, Cultured; Female; Glyburide; Humans; In

2017
Placental Drug Transport-on-a-Chip: A Microengineered In Vitro Model of Transporter-Mediated Drug Efflux in the Human Placental Barrier.
    Advanced healthcare materials, 2018, Volume: 7, Issue:2

    Topics: Female; Glyburide; Humans; Lab-On-A-Chip Devices; Placenta; Pregnancy

2018
Pharmacological treatment of gestational diabetes mellitus: point/counterpoint.
    American journal of obstetrics and gynecology, 2018, Volume: 218, Issue:5

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Metformin; Pregnancy

2018
Role of AKR1C3 in renal injury and glibenclamide is anti-inflammatory in preeclamptic rats.
    Gene, 2018, Jul-01, Volume: 662

    Topics: Acute Kidney Injury; Aldo-Keto Reductase Family 1 Member C3; Animals; Anti-Inflammatory Agents; Dise

2018
Insulin vs Glyburide for Gestational Diabetes.
    JAMA, 2018, 05-01, Volume: 319, Issue:17

    Topics: Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Pregn

2018
Needle beats pill in gestational diabetes mellitus.
    Nature reviews. Endocrinology, 2018, Volume: 14, Issue:8

    Topics: Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Pregn

2018
Glyburide vs Insulin for Gestational Diabetes.
    JAMA, 2018, 10-02, Volume: 320, Issue:13

    Topics: Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents;

2018
Glyburide vs Insulin for Gestational Diabetes-Reply.
    JAMA, 2018, 10-02, Volume: 320, Issue:13

    Topics: Blood Glucose; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents;

2018
Retrospective cohort study comparing neonatal outcomes of women treated with glyburide or insulin in gestational diabetes: a 5-year experience in a South Indian teaching hospital.
    Indian journal of medical sciences, 2011, Volume: 65, Issue:11

    Topics: Adult; Birth Weight; Blood Glucose; Diabetes, Gestational; Female; Fetal Macrosomia; Glyburide; Hosp

2011
A pharmacologic approach to the use of glyburide in pregnancy.
    Obstetrics and gynecology, 2013, Volume: 121, Issue:6

    Topics: Administration, Oral; Blood Glucose; C-Peptide; Diabetes, Gestational; Female; Glyburide; Humans; Hy

2013
Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19.
    British journal of clinical pharmacology, 2014, Volume: 77, Issue:3

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Biotransformation; Computer Simulation; Cytochrome P-450 CYP

2014
Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study.
    American journal of obstetrics and gynecology, 2013, Volume: 209, Issue:6

    Topics: Analysis of Variance; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette

2013
Comment on 'Glyburide as treatment option for gestational diabetes mellitus'.
    The journal of obstetrics and gynaecology research, 2014, Volume: 40, Issue:2

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Pregnancy

2014
Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011.
    Obstetrics and gynecology, 2014, Volume: 123, Issue:6

    Topics: Adolescent; Adult; Comorbidity; Diabetes, Gestational; Female; Glyburide; Humans; Hyperandrogenism;

2014
Maternal-fetal disposition of glyburide in pregnant mice is dependent on gestational age.
    The Journal of pharmacology and experimental therapeutics, 2014, Volume: 350, Issue:2

    Topics: Animals; Area Under Curve; Cytochrome P-450 CYP3A; Female; Fetus; Gestational Age; Glyburide; Hypogl

2014
Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011.
    Obstetrics and gynecology, 2014, Volume: 124, Issue:3

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Practice Patterns, Physicians

2014
Quantitative determination of metformin, glyburide and its metabolites in plasma and urine of pregnant patients by LC-MS/MS.
    Biomedical chromatography : BMC, 2015, Volume: 29, Issue:4

    Topics: Adult; Chromatography, High Pressure Liquid; Diabetes, Gestational; Female; Glyburide; Humans; Hypog

2015
Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes.
    Diabetes care, 2014, Volume: 37, Issue:12

    Topics: Adult; Congenital Hyperinsulinism; Diabetes Mellitus; Female; Fetal Macrosomia; Glyburide; Humans; H

2014
Which oral hypoglycaemic for gestational diabetes?
    BMJ (Clinical research ed.), 2015, Jan-21, Volume: 350

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Metformin; Pregnancy

2015
Glyburide transport across the human placenta.
    Obstetrics and gynecology, 2015, Volume: 125, Issue:3

    Topics: Adult; Diabetes, Gestational; Female; Fetal Blood; Glyburide; Humans; Hypoglycemic Agents; Maternal-

2015
Glyburide for gestational diabetes: time for a pause for thought.
    JAMA pediatrics, 2015, Volume: 169, Issue:5

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Pregnancy; Pregnancy

2015
Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes.
    JAMA pediatrics, 2015, Volume: 169, Issue:5

    Topics: Adult; Cohort Studies; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Infant

2015
Use of glyburide to treat gestational diabetes is linked to adverse outcomes in babies, study finds.
    BMJ (Clinical research ed.), 2015, Mar-30, Volume: 350

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Pregnancy; Pregnancy

2015
Endoplasmic reticulum stress is increased in adipose tissue of women with gestational diabetes.
    PloS one, 2015, Volume: 10, Issue:4

    Topics: Adipose Tissue; Adult; Biomarkers; Caspase 1; Connexins; Diabetes, Gestational; Endoplasmic Reticulu

2015
Diabetes: Therapy for gestational diabetes mellitus--time for a change?
    Nature reviews. Endocrinology, 2015, Volume: 11, Issue:6

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Metformin; Pregnancy

2015
ATP-sensitive potassium channels modulate in vitro tocolytic effects of β₂-adrenergic receptor agonists on uterine muscle rings in rats in early but not in late pregnancy.
    Croatian medical journal, 2015, Volume: 56, Issue:2

    Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Drug Synergism; Female; Glyburide; In Vitro

2015
Weight gain in gestational diabetes: the effect of treatment modality.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2016, Volume: 29, Issue:7

    Topics: Adult; Blood Glucose; Diabetes, Gestational; Diet Therapy; Female; Glyburide; Humans; Insulin; Pregn

2016
In women with gestational diabetes requiring drug treatment, glibenclamide may be inferior to insulin and metformin: metformin (plus insulin when required) performs better than insulin.
    Evidence-based medicine, 2015, Volume: 20, Issue:4

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Metformin; Pregnancy

2015
Examining the Starting Dose of Glyburide in Gestational Diabetes.
    American journal of perinatology, 2016, Volume: 33, Issue:2

    Topics: Adult; Birth Weight; Cesarean Section; Cohort Studies; Diabetes, Gestational; Dystocia; Female; Feta

2016
Glyburide vs Insulin and Adverse Pregnancy Outcomes.
    JAMA pediatrics, 2015, Volume: 169, Issue:10

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Practice Patterns, P

2015
Glyburide vs Insulin and Adverse Pregnancy Outcomes.
    JAMA pediatrics, 2015, Volume: 169, Issue:10

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Pregnancy; Pregnancy

2015
Glyburide vs Insulin and Adverse Pregnancy Outcomes--Reply.
    JAMA pediatrics, 2015, Volume: 169, Issue:10

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Pregnancy; Pregnancy

2015
Predicting failure of glyburide therapy in gestational diabetes.
    Journal of perinatology : official journal of the California Perinatal Association, 2016, Volume: 36, Issue:5

    Topics: Adult; Blood Glucose; Cohort Studies; Diabetes, Gestational; Dose-Response Relationship, Drug; Drug

2016
Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter.
    The Journal of pharmacology and experimental therapeutics, 2016, Volume: 357, Issue:1

    Topics: Adolescent; Adult; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Tra

2016
Non-insulin pharmacological therapy in pregnancy.
    JPMA. The Journal of the Pakistan Medical Association, 2016, Volume: 66, Issue:9 Suppl 1

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Metformin; Pregnancy

2016
Insulin detemir versus glyburide in women with gestational diabetes mellitus.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016, Volume: 32, Issue:11

    Topics: Adult; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin Detemir; Outco

2016
The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta.
    Placenta, 2008, Volume: 29, Issue:8

    Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biologic

2008
Investigating the potential role of multi-drug resistance protein (MRP) transporters in fetal to maternal glyburide efflux in the human placenta.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2008, Volume: 28, Issue:5

    Topics: Adult; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Indomethacin; Male; Ma

2008
Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1.
    Circulation research, 2009, Mar-13, Volume: 104, Issue:5

    Topics: Apolipoprotein A-I; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily

2009
Glibenclamide improves neurological function in neonatal hypoxia-ischemia in rats.
    Brain research, 2009, May-13, Volume: 1270

    Topics: Animals; Animals, Newborn; ATP-Binding Cassette Transporters; Behavior, Animal; Blood Glucose; Brain

2009
Chronic nicotine blunts hypoxic sensitivity in perinatal rat adrenal chromaffin cells via upregulation of KATP channels: role of alpha7 nicotinic acetylcholine receptor and hypoxia-inducible factor-2alpha.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Jun-03, Volume: 29, Issue:22

    Topics: Adrenal Glands; alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Animals, New

2009
Maternal serum adiponectin multimers in gestational diabetes.
    Journal of perinatal medicine, 2009, Volume: 37, Issue:6

    Topics: Adiponectin; Adult; Body Mass Index; Case-Control Studies; Cross-Sectional Studies; Diabetes, Gestat

2009
Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide.
    Biochemical pharmacology, 2009, Dec-15, Volume: 78, Issue:12

    Topics: Antibodies; Cross Reactions; Cytochrome P-450 Enzyme System; Female; Glyburide; Humans; Isoenzymes;

2009
Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility.
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 331, Issue:3

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter,

2009
[Oral blood glucose-lowering medication as a monotherapy in gestational diabetes: a hotly debated topic].
    Nederlands tijdschrift voor geneeskunde, 2009, Volume: 153

    Topics: Administration, Oral; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin

2009
Glyburide: caution for efficacy and fetal programming effects.
    American journal of obstetrics and gynecology, 2010, Volume: 202, Issue:4

    Topics: Adipose Tissue; Birth Weight; Diabetes, Gestational; Female; Fetal Development; Glyburide; Humans; H

2010
Impact of hyperlipidemia on plasma protein binding and hepatic drug transporter and metabolic enzyme regulation in a rat model of gestational diabetes.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 334, Issue:1

    Topics: Animals; Binding, Competitive; Biological Transport; Blood Proteins; Carrier Proteins; Chromatograph

2010
Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin.
    American journal of obstetrics and gynecology, 2010, Volume: 202, Issue:4

    Topics: Adenosine Triphosphate; Biological Transport; Carbon Radioisotopes; Carrier Proteins; Cell Polarity;

2010
Increased glyburide clearance in the pregnant mouse model.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:9

    Topics: Animals; Disease Models, Animal; Female; Glyburide; Hypoglycemic Agents; Mice; Pregnancy

2010
Adrenomedullin relaxes rat uterine artery: mechanisms and influence of pregnancy and estradiol.
    Endocrinology, 2010, Volume: 151, Issue:9

    Topics: Adrenomedullin; Animals; Calcitonin Gene-Related Peptide; Dose-Response Relationship, Drug; Endothel

2010
Contribution of potassium in human placental steroidogenesis.
    Placenta, 2010, Volume: 31, Issue:10

    Topics: Blotting, Western; Cholesterol; Female; Glyburide; Humans; Ionophores; KATP Channels; Membrane Poten

2010
Clinical outcomes of pregnancies complicated by mild gestational diabetes mellitus differ by combinations of abnormal oral glucose tolerance test values.
    Diabetes care, 2010, Volume: 33, Issue:12

    Topics: Adult; Diabetes, Gestational; Exercise; Female; Glucose Tolerance Test; Glyburide; Humans; Hypoglyce

2010
Glyburide in gestational diabetes--prediction of treatment failure.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2011, Volume: 24, Issue:6

    Topics: Adult; Biomarkers, Pharmacological; Birth Weight; Diabetes, Gestational; Female; Gestational Age; Gl

2011
Hypoglycemia in glyburide-treated gestational diabetes: is it dose-dependent?
    Obstetrics and gynecology, 2011, Volume: 117, Issue:2 Pt 1

    Topics: Adult; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Pregnanc

2011
Neonatal chemical hypoglycemia in newborns from pregnancies complicated by type 2 and gestational diabetes mellitus - the importance of neonatal ponderal index.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2012, Volume: 25, Issue:3

    Topics: Birth Weight; Blood Glucose; Cohort Studies; Diabetes Mellitus, Type 2; Diabetes, Gestational; Femal

2012
Oral hypoglycemic agents in pregnancy.
    Obstetrics and gynecology clinics of North America, 2011, Volume: 38, Issue:2

    Topics: Administration, Oral; Breast Feeding; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic

2011
Treatment of gestational diabetes mellitus: glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2012, Volume: 25, Issue:4

    Topics: Adolescent; Adult; Cohort Studies; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Ag

2012
Hypoglycemia in glyburide-treated gestational diabetes: is it dose-dependent?
    Obstetrics and gynecology, 2011, Volume: 118, Issue:2 Pt 1

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Pregnancy

2011
[Ontogeny of sulphonylurea-binding regulatory subunits of K(ATP) channels in the pregnant rat myometrium].
    Acta pharmaceutica Hungarica, 2011, Volume: 81, Issue:3

    Topics: Animals; ATP-Binding Cassette Transporters; Blotting, Western; Diazoxide; Female; Gene Expression Re

2011
The effect of maternal obesity on pregnancy outcomes of women with gestational diabetes controlled with diet only, glyburide, or insulin.
    American journal of perinatology, 2012, Volume: 29, Issue:8

    Topics: Comorbidity; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Logisti

2012
A new slow releasing, H₂S generating compound, GYY4137 relaxes spontaneous and oxytocin-stimulated contractions of human and rat pregnant myometrium.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Adult; Animals; Calcium Channels, L-Type; Dose-Response Relationship, Drug; Female; Glyburide; Human

2012
Small-molecule inhibitors of the cystic fibrosis transmembrane conductance regulator increase pancreatic endocrine cell development in rat and mouse.
    Diabetologia, 2013, Volume: 56, Issue:2

    Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Cystic Fibrosis Transmembrane Conductance Reg

2013
Evidence of K and Ca channels in endothelial cells of human allantochorial placental vessels.
    Cellular and molecular biology (Noisy-le-Grand, France), 2002, Volume: 48 Online Pub

    Topics: Acetylcholine; Allantois; Blood Vessels; Calcium Channels; Chorion; Endothelium, Vascular; Female; G

2002
Glibenclamide inhibits islet carnitine palmitoyltransferase 1 activity, leading to PKC-dependent insulin exocytosis.
    American journal of physiology. Endocrinology and metabolism, 2003, Volume: 285, Issue:2

    Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Membrane; Diglycerides; Enzyme Inhibitors; Exocytosi

2003
YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits the spontaneous contractions of isolated pregnant rat myometrium.
    Journal of pharmacological sciences, 2004, Volume: 94, Issue:1

    Topics: Animals; Depression, Chemical; Dose-Response Relationship, Drug; Enzyme Activators; Female; Glyburid

2004
Synopsis of the North American Diabetes in Pregnancy Study Group Conference in Little Rock, Arkansas, May 2003.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2004, Volume: 15, Issue:1

    Topics: Blood Glucose; Caffeine; Cesarean Section; Congenital Abnormalities; Delivery, Obstetric; Diabetes,

2004
Use of glyburide for the treatment of gestational diabetes: the San Antonio experience.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2004, Volume: 15, Issue:1

    Topics: Adult; Blood Glucose; Diabetes, Gestational; Dose-Response Relationship, Drug; Drug Administration S

2004
Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus.
    Journal of perinatology : official journal of the California Perinatal Association, 2004, Volume: 24, Issue:10

    Topics: Adult; Blood Glucose; Diabetes, Gestational; Dose-Response Relationship, Drug; Drug Administration S

2004
Glyburide for the treatment of gestational diabetes.
    American journal of obstetrics and gynecology, 2004, Volume: 190, Issue:5

    Topics: Adult; Blood Glucose; Cohort Studies; Confidence Intervals; Diabetes, Gestational; Diet, Diabetic; D

2004
Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy.
    Obstetrics and gynecology, 2004, Volume: 104, Issue:1

    Topics: Adult; Blood Glucose; Diabetes, Gestational; Diet, Diabetic; Female; Glyburide; Humans; Hypoglycemia

2004
Breakthrough in treating gestational diabetes mellitus.
    Canadian family physician Medecin de famille canadien, 2004, Volume: 50

    Topics: Adult; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Manitoba; Pat

2004
Prostaglandin E2--mediated relaxation of the ductus arteriosus: effects of gestational age on g protein-coupled receptor expression, signaling, and vasomotor control.
    Circulation, 2004, Oct-19, Volume: 110, Issue:16

    Topics: 16,16-Dimethylprostaglandin E2; 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Adenylyl Cyclases

2004
Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome.
    American journal of obstetrics and gynecology, 2005, Volume: 192, Issue:1

    Topics: Administration, Oral; Blood Glucose; Diabetes, Gestational; Drug Administration Schedule; Female; Fe

2005
Impaired KATP channel function in the fetoplacental circulation of patients with type 1 diabetes mellitus.
    American journal of obstetrics and gynecology, 2005, Volume: 192, Issue:3

    Topics: 4-Aminopyridine; Charybdotoxin; Diabetes Mellitus, Type 1; Endothelial Cells; Female; Glyburide; Hum

2005
Glyburide: the new alternative for treating gestational diabetes?
    American journal of obstetrics and gynecology, 2005, Volume: 193, Issue:1

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Pregnancy

2005
Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
    American journal of obstetrics and gynecology, 2005, Volume: 193, Issue:1

    Topics: Adult; Birth Weight; Blood Glucose; Diabetes, Gestational; Fasting; Female; Glucose Tolerance Test;

2005
Effects of calcium channel blocker, mibefradil, and potassium channel opener, pinacidil, on the contractile response of mid-pregnant goat myometrium.
    Indian journal of experimental biology, 2005, Volume: 43, Issue:9

    Topics: Adenosine Triphosphate; Animals; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female;

2005
Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety.
    American journal of obstetrics and gynecology, 2006, Volume: 195, Issue:1

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Female; Fetus

2006
Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
    American journal of obstetrics and gynecology, 2006, Volume: 195, Issue:2

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Managed Care Program

2006
Predictors of glyburide failure in the treatment of gestational diabetes.
    Obstetrics and gynecology, 2006, Volume: 107, Issue:6

    Topics: Adult; Cesarean Section; Diabetes, Gestational; Female; Fetal Macrosomia; Glyburide; Humans; Hypogly

2006
Effect of human serum albumin on transplacental transfer of glyburide.
    Biochemical pharmacology, 2006, Aug-28, Volume: 72, Issue:5

    Topics: Female; Glyburide; Humans; Hypoglycemic Agents; Maternal-Fetal Exchange; Placenta; Pregnancy

2006
The effects of volatile anesthetics on spontaneous contractility of isolated human pregnant uterine muscle: a comparison among sevoflurane, desflurane, isoflurane, and halothane.
    Anesthesia and analgesia, 2006, Volume: 103, Issue:2

    Topics: Anesthetics, Inhalation; Calcium; Desflurane; Dose-Response Relationship, Drug; Female; Glyburide; H

2006
Role of ATP-sensitive potassium channels in normal and hypertension-associated pregnancy in rats.
    Clinical and experimental pharmacology & physiology, 2006, Volume: 33, Issue:9

    Topics: Adenosine Triphosphate; Animals; Blood Glucose; Blood Pressure; Female; Glyburide; Hypertension, Pre

2006
Role of ATP-dependent potassium channels in pulmonary vascular tone of fetal lambs with congenital diaphragmatic hernia.
    Pediatric research, 2006, Volume: 60, Issue:5

    Topics: Adenosine Triphosphate; Animals; Female; Glyburide; Hernia, Diaphragmatic; Hernias, Diaphragmatic, C

2006
Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes.
    American journal of obstetrics and gynecology, 2006, Volume: 195, Issue:4

    Topics: Adult; Diabetes, Gestational; Female; Glucose Tolerance Test; Glyburide; Humans; Hypoglycemic Agents

2006
Drugs in pregnancy: acknowledging challenges--finding solutions.
    The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique, 2007,Winter, Volume: 14, Issue:1

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Canada; Clinical Trials as Topic; Drug Industry;

2007
Case 36-2006: a pregnant woman with new hypertension.
    The New England journal of medicine, 2007, Mar-01, Volume: 356, Issue:9

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Diabetes, Gestational; Female; Glyburide; Humans

2007
Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia.
    Journal of perinatology : official journal of the California Perinatal Association, 2007, Volume: 27, Issue:5

    Topics: Adult; Blood Glucose Self-Monitoring; Combined Modality Therapy; Diabetes, Gestational; Diet, Diabet

2007
Gestational diabetes mellitus: what is the optimal treatment modality?
    Journal of perinatology : official journal of the California Perinatal Association, 2007, Volume: 27, Issue:5

    Topics: Diabetes, Gestational; Diet, Diabetic; Exercise; Female; Glyburide; Humans; Hypoglycemic Agents; Inf

2007
Kinetics of glyburide metabolism by hepatic and placental microsomes of human and baboon.
    Biochemical pharmacology, 2007, Jun-15, Volume: 73, Issue:12

    Topics: Animals; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Female; Glyburide; Humans

2007
Validation of a sensitive LC-MS assay for quantification of glyburide and its metabolite 4-transhydroxy glyburide in plasma and urine: an OPRU Network study.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Dec-01, Volume: 860, Issue:1

    Topics: Chromatography, High Pressure Liquid; Diabetes, Gestational; Female; Glucuronidase; Glyburide; Human

2007
A simple and rapid HPLC method for the detection of glyburide in plasma original research communication (analytical).
    Clinical biochemistry, 2008, Volume: 41, Issue:3

    Topics: Chemical Fractionation; Chromatography, High Pressure Liquid; Diabetes, Gestational; Drug Monitoring

2008
The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study.
    Molecular pharmacology, 2008, Volume: 73, Issue:3

    Topics: Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cass

2008
The effectiveness of glibenclamide in women with gestational diabetes.
    Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:10

    Topics: Adult; Analysis of Variance; Asia; Case-Control Studies; Chi-Square Distribution; Diabetes, Gestatio

2008
Glyburide is a safe and effective treatment for gestational diabetes.
    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2008, Volume: 30, Issue:2

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Pregnancy; Treatment

2008
Effect of albumin on transplacental transfer and distribution of rosiglitazone and glyburide.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2008, Volume: 21, Issue:3

    Topics: Female; Fetal Blood; Glyburide; Humans; Hypoglycemic Agents; In Vitro Techniques; Maternal-Fetal Exc

2008
Glyburide metabolism by placentas of healthy and gestational diabetics.
    American journal of perinatology, 2008, Volume: 25, Issue:3

    Topics: Adult; Chromatography, Liquid; Diabetes, Gestational; Diet, Diabetic; Female; Glyburide; Humans; Hyp

2008
Effect of endotoxin on the expression of placental drug transporters and glyburide disposition in pregnant rats.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:9

    Topics: Animals; ATP-Binding Cassette Transporters; Blotting, Western; Chromatography, High Pressure Liquid;

2008
Gap junctions in several tissues share antigenic determinants with liver gap junctions.
    The EMBO journal, 1984, Volume: 3, Issue:10

    Topics: Animals; Epitopes; Female; Fluorescent Antibody Technique; Glyburide; Histocytochemistry; Immunosorb

1984
Pregnancy in established non-insulin-dependent diabetics. A five-and-a-half year study at Groote Schuur Hospital.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1980, Nov-15, Volume: 58, Issue:20

    Topics: Diabetes Mellitus; Female; Glyburide; Humans; Infant Mortality; Insulin; Labor, Induced; Metformin;

1980
Interrelationship of insulin and somatomedin activity in fetal rats.
    Biology of the neonate, 1982, Volume: 41, Issue:5-6

    Topics: Animals; Blood Glucose; Body Weight; Female; Fetus; Glucose; Glyburide; Insulin; Male; Maternal-Feta

1982
Glyburide crosses the placenta in vivo in pregnant rats.
    Diabetologia, 1995, Volume: 38, Issue:7

    Topics: Animals; Carbon Radioisotopes; Diazepam; Female; Fetus; Gestational Age; Glyburide; Hypoglycemic Age

1995
Insulin-dependent diabetes of pregnancy treated with the combination of sulfonylurea and insulin.
    Israel journal of medical sciences, 1995, Volume: 31, Issue:10

    Topics: Adult; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetes, Gestational; Drug Administrat

1995
The role of endothelin and endothelin receptor subtypes in regulation of fetal pulmonary vascular tone.
    Pediatric research, 1994, Volume: 35, Issue:6

    Topics: Animals; Endothelin Receptor Antagonists; Endothelins; Female; Fetus; Glyburide; Peptides, Cyclic; P

1994
Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer.
    American journal of obstetrics and gynecology, 1994, Volume: 171, Issue:3

    Topics: Administration, Oral; Analysis of Variance; Antipyrine; Biological Transport; Chlorpropamide; Chroma

1994
Effects of metabolic inhibition and changes of intracellular pH on potassium permeability and contraction of rat uterus.
    The Journal of physiology, 1993, Volume: 465

    Topics: Adenosine Triphosphate; Animals; Antimetabolites; Cell Hypoxia; Cyanides; Female; Glyburide; Hydroge

1993
Relaxation by calcitonin gene-related peptide may involve activation of K+ channels in the human uterine artery.
    European journal of pharmacology, 1993, Oct-05, Volume: 242, Issue:3

    Topics: Adenosine Triphosphate; Adult; Arteries; Calcitonin Gene-Related Peptide; Female; Glyburide; Guanidi

1993
Sulfonylurea receptor expression in rat brain: effect of chronic hypoxia during development.
    Pediatric research, 1993, Volume: 34, Issue:5

    Topics: Animals; Animals, Newborn; ATP-Binding Cassette Transporters; Brain; Female; Fetal Hypoxia; Glyburid

1993
Inhibition of contractions of the isolated human myometrium by potassium channel openers.
    American journal of obstetrics and gynecology, 1993, Volume: 168, Issue:3 Pt 1

    Topics: Benzopyrans; Cromakalim; Female; Glyburide; Humans; Ion Channel Gating; Oxytocin; Parasympatholytics

1993
Oxygen causes fetal pulmonary vasodilation through activation of a calcium-dependent potassium channel.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Jul-23, Volume: 93, Issue:15

    Topics: Alkaloids; Aminoquinolines; Animals; Carbazoles; Charybdotoxin; Endothelium, Vascular; Enzyme Inhibi

1996
Ventilation-induced pulmonary vasodilation at birth is modulated by potassium channel activity.
    The American journal of physiology, 1996, Volume: 271, Issue:6 Pt 2

    Topics: Adenosine Triphosphate; Animals; Female; Fetus; Glyburide; Labor, Obstetric; Oxygen; Potassium Chann

1996
KATP channel activation in a rabbit model of chronic myocardial hypoxia.
    Journal of molecular and cellular cardiology, 1997, Volume: 29, Issue:2

    Topics: Action Potentials; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Animals, Newborn; Chronic

1997
Activation of large-conductance potassium channels in pregnant human myometrium by pinacidil.
    American journal of obstetrics and gynecology, 1998, Volume: 178, Issue:5

    Topics: Calcium; Charybdotoxin; Electric Conductivity; Female; Glyburide; Guanidines; Humans; Muscle Relaxat

1998
Effect of K+ATP channel inhibition on total and regional vascular resistance in guinea pig pregnancy.
    The American journal of physiology, 1998, Volume: 275, Issue:2

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiac Output; Female; Glyburide; Guinea Pigs; Hemodynamic

1998
Hyperpolarization and slowing of the rate of contraction in human uterus in pregnancy by prostaglandins E2 and f2alpha: involvement of the Na+ pump.
    The Journal of physiology, 1999, Jan-01, Volume: 514 ( Pt 1)

    Topics: Albuterol; Calcium; Calcium Channel Blockers; Charybdotoxin; Cyclic AMP; Dinoprost; Dinoprostone; En

1999
Mechanisms of adrenomedullin-induced increase of pulmonary blood flow in fetal sheep.
    Pediatric research, 1999, Volume: 45, Issue:2

    Topics: Adrenomedullin; Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor A

1999
Post-partum prolongation of the atrial repolarization in rabbit.
    Acta physiologica Scandinavica, 1999, Volume: 166, Issue:1

    Topics: 4-Aminopyridine; Action Potentials; Animals; Atrial Function; Electrophysiology; Estrogens; Female;

1999
Roles of potassium channels and nitric oxide in modulation of uterine contractions in rat pregnancy.
    American journal of obstetrics and gynecology, 1999, Volume: 181, Issue:3

    Topics: Adenosine Triphosphate; Animals; Benzimidazoles; Cromakalim; Female; Gestational Age; Glyburide; In

1999
cAMP-activated anion conductance is associated with expression of CFTR in neonatal mouse cardiac myocytes.
    American journal of physiology. Cell physiology, 2000, Volume: 278, Issue:2

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adenosine Triphosphate; Animals; Animals, Newborn;

2000
Effects of potassium channel modulators on myotropic responses of aortic rings of pregnant rats.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 278, Issue:2

    Topics: Animals; Aorta; Benzimidazoles; Cromakalim; Female; Glyburide; In Vitro Techniques; Muscle, Smooth,

2000
A comparison between the pregnancy outcome of women with gestation diabetes treated with glibenclamide and those treated with insulin.
    The Medical journal of Malaysia, 1997, Volume: 52, Issue:4

    Topics: Birth Weight; Diabetes, Gestational; Female; Fetal Macrosomia; Glyburide; Humans; Hypoglycemic Agent

1997
Guanylate cyclase and not ATP-dependent K(+) channels seems temperature-dependent in smooth muscle relaxation of human umbilical arteries.
    European journal of pharmacology, 2000, Oct-06, Volume: 406, Issue:1

    Topics: Adenosine Triphosphate; Arginine; Cromakalim; Dose-Response Relationship, Drug; Female; Glyburide; G

2000
Oral hypoglycemic drugs for gestational diabetes.
    The New England journal of medicine, 2000, Oct-19, Volume: 343, Issue:16

    Topics: Blood Glucose; Congenital Abnormalities; Diabetes, Gestational; Female; Fetal Blood; Fetal Macrosomi

2000
Chronic hypoxia increases the NO contribution of acetylcholine vasodilation of the fetal guinea pig heart.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2000, Volume: 279, Issue:5

    Topics: 4-Aminopyridine; Acetylcholine; Animals; Coronary Vessels; Female; Fetal Hypoxia; Gene Expression Re

2000
Oxygen dilation in fetal pulmonary arterioles: role of K(+) channels.
    The Journal of surgical research, 2001, May-15, Volume: 97, Issue:2

    Topics: 4-Aminopyridine; Animals; Arterioles; Charybdotoxin; Female; Fetus; Glyburide; Hypoglycemic Agents;

2001
The use of glyburide in gestational diabetes--an ideal example of "bench to bedside".
    Pediatric research, 2001, Volume: 49, Issue:6

    Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; In Vitro Techniques; Insulin;

2001
A comparison of glyburide and insulin in women with gestational diabetes mellitus.
    Diabetic medicine : a journal of the British Diabetic Association, 2001, Volume: Suppl 3

    Topics: Adult; Diabetes, Gestational; Female; Glucose Intolerance; Glyburide; Humans; Hypoglycemic Agents; I

2001
The role of K(+) channels on the inhibitor effect of sevoflurane in pregnant rat myometrium.
    Anesthesia and analgesia, 2002, Volume: 94, Issue:1

    Topics: Adenosine Triphosphate; Anesthetics, Inhalation; Animals; Dose-Response Relationship, Drug; Female;

2002
Beta-adrenoceptor-mediated control of apical membrane conductive properties in fetal distal lung epithelia.
    American journal of physiology. Lung cellular and molecular physiology, 2002, Volume: 282, Issue:4

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adrenergic beta-Agonists; Animals; Barium; Cell Po

2002
Polyamine effects on human myometrial contractility.
    American journal of obstetrics and gynecology, 2002, Volume: 186, Issue:4

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e

2002
Diabetes newly diagnosed during pregnancy: A 4-year study at Groote Schuur Hospital.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1979, Sep-01, Volume: 56, Issue:12

    Topics: Adolescent; Adult; Birth Weight; Black or African American; Black People; Delivery, Obstetric; Diabe

1979
Insulin secretion in the perinatal period of the rat in vivo and in vitro effects of glucose and gibenclamide (HB 419).
    Diabetologia, 1975, Volume: 11, Issue:4

    Topics: Animals; Animals, Newborn; Female; Fetus; Glucose; Glyburide; In Vitro Techniques; Insulin; Insulin

1975
In vivo cytogenetic activity of sulphonylurea drugs in man.
    Mutation research, 1976, Volume: 38, Issue:1

    Topics: Adult; Chlorpropamide; Chromosome Aberrations; Chromosome Deletion; Diabetes Mellitus; Female; Glybu

1976
[Effects of hypoglycemic agents on development of the eye of rat embryos (author's transl)].
    Nippon Ganka Gakkai zasshi, 1976, Volume: 80, Issue:10

    Topics: Animals; Carbutamide; Eye; Female; Glyburide; Humans; Infant, Newborn; Pregnancy; Rats

1976
Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium.
    Proceedings of the Western Pharmacology Society, 1992, Volume: 35

    Topics: Animals; Benzopyrans; Calcium; Cromakalim; Female; Glyburide; Guanidines; Humans; In Vitro Technique

1992
K+ channel pulmonary vasodilation in fetal lambs: role of endothelium-derived nitric oxide.
    Journal of applied physiology (Bethesda, Md. : 1985), 1992, Volume: 73, Issue:1

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Acetylcholine; Animals; Arginine; Blood Pressure; Female; Fe

1992
Insignificant transfer of glyburide occurs across the human placenta.
    American journal of obstetrics and gynecology, 1991, Volume: 165, Issue:4 Pt 1

    Topics: Diazepam; Female; Glyburide; Humans; Maternal-Fetal Exchange; Models, Biological; Placenta; Pregnanc

1991
Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
    British journal of pharmacology, 1990, Volume: 101, Issue:4

    Topics: Animals; Benzopyrans; Blood Pressure; Cromakalim; Female; Glyburide; Guanidines; Heart Rate; Hemodyn

1990
[Importance of calcium in the interaction between prostaglandins E and sulfonylureas in utero].
    Archivos de farmacologia y toxicologia, 1986, Volume: 12, Issue:1

    Topics: Animals; Calcium; Dose-Response Relationship, Drug; Drug Interactions; Female; Glyburide; Muscle Rel

1986
Mild familial diabetes with dominant inheritance.
    The Quarterly journal of medicine, 1974, Volume: 43, Issue:170

    Topics: Acetohexamide; Adolescent; Adult; Aged; Blood Glucose; Carbohydrates; Child; Chlorpropamide; Diabete

1974
[The influece of hypoglycemia, induced by parenterally administred glibenclamide during gravidity of the rat, on the perinatal mortality of the offspring].
    Arzneimittel-Forschung, 1971, Volume: 21, Issue:6

    Topics: Animals; Animals, Newborn; Cyclohexanes; Embryo Implantation; Female; Fetal Death; Glyburide; Hypogl

1971